<!DOCTYPE html><html lang="zh-CN"><head><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta charset="utf-8"><meta property="qc:admins" content="10210420621156375"><meta name="renderer" content="webkit"><title>zangyn - 雪球</title><script>var _write = document.write;
var write = function (str) {
  SNB = window.SNB || {};
  if (_write.apply) {
    SNB.docWrite = function (str) {
      _write.apply(document, arguments);
    }
  } else {
    SNB.docWrite = _write;
  }
};

document.write = write;
</script><meta name="keywords" content="zangyn - 雪球"><meta name="description" content="zangyn - 雪球"><!--<link rel="shortcut icon" href="http://xueqiu.com/favicon.ico">--><link rel="icon" type="image/png" href="http://assets.imedao.com/images/favicon.png"><style>html {display:none}</style><script>if (self == top) {
  document.documentElement.style.display = 'block';
} else if (top.location.host !== 'xueqiu.com') {
  top.location = self.location;
}
var WATCH = {};
WATCH.appStart = 1427781337316
WATCH.pageStart = (new Date()).getTime()</script><link rel="stylesheet" href="http://assets.imedao.com/style/bootstrap-84b5ee.css"><style>body{
  padding-top:40px;
}
/* TODO */
.search .dropdown-menu strong{
  height:12px;
  line-height:12px;
}</style><link rel="apple-touch-icon-precomposed" href="http://assets.imedao.com/images/icon-144.png"><script src="http://assets.imedao.com/js/xdomain-0.6.15.js"></script><script>xdomain.slaves({
  'https://xueqiu.com': '/proxy2.html',
  'https://im0.xueqiu.com': '/proxy2.html',
  'https://im1.xueqiu.com': '/proxy2.html',
  'https://im2.xueqiu.com': '/proxy2.html',
  'https://im3.xueqiu.com': '/proxy2.html',
  'https://im4.xueqiu.com': '/proxy2.html',
  'https://im5.xueqiu.com': '/proxy2.html',
  'https://im6.xueqiu.com': '/proxy2.html',
  'https://im7.xueqiu.com': '/proxy2.html',
  'https://im8.xueqiu.com': '/proxy2.html',
  'https://im9.xueqiu.com': '/proxy2.html'
});</script><script src="http://assets.imedao.com/js/SNB.lib.bundle-b11b47.js"></script></head><body id="his-profile" class=" isPC isNotMobile isNotPad"><script>SNB = window.SNB || {};
jQuery.extend(SNB, {
  data: {},
  env: "production",
  Views: {},
  Templates: {},
  Models: {},
  Collections: {},
  domain: {"host":"http://xueqiu.com","base":"http://api.xueqiu.com","photo":"http://photo.xueqiu.com","stock":"http://api.xueqiu.com","static":"http://assets.imedao.com","staticHttps":"https://js.xueqiu.com","upyun":"http://xqimg.b0.upaiyun.com","pdf":"http://doc.xueqiu.com","im":"http://api.xueqiu.com","shared":"/data/source/snowball-fe/shared/","file":"http://xqfile.imedao.com/"},
  currentUser: {"isGuest":true,"enableIM":true},
  jsVersion: {"05.jquery.cookie.js":"68e2a4","08.templates.js":"4aa7bf","SNB.TopicList.js":"870445","SNB.UsersList.js":"34f02b","SNB.atDialog.js":"b5dce3","SNB.base.js":"0e6b16","SNB.base_simple.js":"8d5f63","SNB.bind_verify.js":"118df1","SNB.calendar.js":"c65d9a","SNB.calendarDialog.js":"929cb0","SNB.calendarSubscribe.js":"e6012c","SNB.capitalReturnRateChart.js":"bd11c3","SNB.cardDialog.js":"ab3d1d","SNB.commentView.js":"bbb8d8","SNB.commonFriends.js":"230e08","SNB.companyInfo.js":"86e7f2","SNB.dialog.js":"1ba7c4","SNB.dm.js":"4c9d34","SNB.dmDialog.js":"c96117","SNB.downloadDialog.js":"68595d","SNB.editor.emotion.js":"ccd772","SNB.editor.js":"adb8a9","SNB.eventShare.js":"7b230c","SNB.financeTableDataInfo.js":"63138a","SNB.follower.js":"83577e","SNB.friends.js":"d90729","SNB.g.bar.js":"8d17c0","SNB.guest.js":"a94f90","SNB.guide.js":"28902b","SNB.helpers.js":"d5327e","SNB.his_home.js":"468d25","SNB.holdStockChart.js":"7fb688","SNB.home.js":"da999e","SNB.hotStock.js":"320cd1","SNB.im.contacts.js":"3d5779","SNB.im.dialog.js":"ee29f9","SNB.im.emotions.js":"158b2d","SNB.im.group_applys.js":"5c11f0","SNB.im.group_joined.js":"3f1895","SNB.im.js":"43351a","SNB.im.message.js":"1c9f8a","SNB.im.model.js":"a8324f","SNB.im.net.js":"ec4486","SNB.im.peer_chat.js":"cb13f1","SNB.im.session_item.js":"bbffaa","SNB.im.sessions_list.js":"eb2ad1","SNB.im.setting.js":"ac0ed0","SNB.im.stranger.js":"8ea9a5","SNB.im.utils.js":"6a455e","SNB.imeigu_fund_topic.js":"712871","SNB.imeigu_index.js":"d4f2e9","SNB.index.login.js":"bba5e1","SNB.inner_trade.js":"7d8321","SNB.interest.js":"eeb1f8","SNB.interview.js":"fa9ef6","SNB.kline.js":"b097fb","SNB.lib.bundle.js":"b11b47","SNB.lib.mobile.js":"8eda9f","SNB.modify_email.js":"0cb2c6","SNB.newChart.js":"453bf1","SNB.newChart.mobile.js":"089c9a","SNB.newProfile.js":"50704d","SNB.password.js":"8bf5ac","SNB.pdfDialog.js":"edc173","SNB.performance-year.js":"55e5b8","SNB.performance.js":"b83bda","SNB.performanceChart.js":"0cc6bc","SNB.performanceView.js":"fde3d9","SNB.performance_mobile.js":"2890ea","SNB.personality.js":"3a3a3d","SNB.portfolio.js":"b332e5","SNB.portfolioNew.js":"291c15","SNB.portfolioShareDialog.js":"b581bf","SNB.profile_info.js":"621d95","SNB.recommend.js":"0444f1","SNB.renderTableTrHtml.js":"d9ecf0","SNB.renderUserView.js":"0ea1a6","SNB.reportSpam.js":"418c1f","SNB.repostDialog.js":"7df4cb","SNB.sameFriend.js":"b18a13","SNB.search.js":"11b42e","SNB.search_ipad.js":"62a216","SNB.search_stock_ipad.js":"6910d7","SNB.setting_user.js":"5d7e30","SNB.shareDialog.js":"1dee89","SNB.similarUsers.js":"72068a","SNB.singleStock.js":"2f733b","SNB.status-edit.js":"a9ae8a","SNB.status.js":"1172f0","SNB.status_mobile.js":"7e19fa","SNB.stockActiveUser.js":"396eeb","SNB.stockFollowers.js":"e124c9","SNB.stockList.js":"941ade","SNB.stockList_new.js":"e5b606","SNB.stockNews.js":"311d94","SNB.stockRecommend.js":"352bad","SNB.stockScreener.js":"352de4","SNB.stockStatus.js":"7af8bd","SNB.talks.js":"e19cae","SNB.third_oauth.js":"1b9e2a","SNB.tipsTalk.js":"83e04f","SNB.tipsTopic.js":"624f0b","SNB.today.js":"ff42db","SNB.today.lib.js":"19681e","SNB.today_topic.js":"9f7844","SNB.tooltip.js":"b57764","SNB.topInfluence.js":"89f31e","SNB.trans.js":"ae4d82","SNB.tweetDialog.js":"9eb539","SNB.typeahead.js":"6c0b76","SNB.userRecommend.js":"5dcade","SNB.userRemark.js":"001ff1","SNB.validator.js":"32794c","SNB.weiboUser.js":"81e080","TGJSBridge.js":"4aaeff","WdatePicker.js":"eb9586","ajaxfileupload.js":"59627b","backbone.0.9.10.js":"5d519b","backbone.js":"d013f1","bootstrap.js":"6bd6fa","calendar.js":"9795e3","checkLogin.js":"38a9a1","config.js":"799ccf","d3.v2.min.js":"1ef3b6","fittext.js":"45db6e","flexpaper.js":"56a735","flexpaper_handlers.js":"623c12","fullcalendar.js":"26781c","g.bar.js":"32785d","g.line-min.js":"2db247","g.pie.js":"46e2f1","g.raphael.js":"630b74","hammer.js":"ec2456","hc_exporting.js":"bb5d9e","hc_grid.js":"3b9851","highcharts.js":"122285","highlight.js":"21d2c6","iScroll.js":"834870","im2014.js":"0216be","im_group_apply.js":"930e3b","imeigu_portfolioIframe.js":"8e3134","imgPlugin.js":"1cb5de","imgUpload.js":"0986a1","infinity.min.js":"0c5941","jquery.color.js":"875798","jquery.galleriffic.js":"e6186f","jquery.hammer.js":"e02a44","jquery.history.js":"6f8651","jquery.imgareaselect.js":"a9d059","jquery.js":"d80a03","jquery.lazyload.min.js":"fb3951","jquery.mousewheel.js":"41ebd2","jquery.pjax.js":"7ccac8","jquery.plugin.pullToRefresh.js":"35465b","jquery.rotate.1-1.js":"60d180","jquery.simplePagination.js":"420bda","jquery.tagsinput.js":"0dce2d","jquery.ui.js":"9ee05e","jquery.uploadify.js":"aac61a","jquery.validate.js":"555531","jquery.vticker.js":"5104ed","jquery.watermark.js":"0cc691","login.js":"094d42","moment.js":"b01d4e","morris.min.js":"92098e","mustache.js":"fbf1b1","perfect-scrollbar-0.4.8.with-mousewheel.min.js":"1bd536","raphael.js":"ea1c64","responsive_slides.min.js":"ea733a","sea.js":"1264a2","share-to-xueqiu.js":"ae4237","single.js":"36ac66","slides.jquery.js":"cd66ff","step01.js":"ceaeeb","subscribe.js":"7d760a","underscore.js":"51b489","userSearch.js":"54d13d","xdomain-0.6.15.js":"575cd5","xdomain.js":"c4e376","zepto.js":"6cdcc6","My97DatePicker/WdatePicker.js":"eb9586","My97DatePicker/calendar.js":"9795e3","SNB.lib.bundle/00.sea.js":"24e81c","SNB.lib.bundle/01.JSON.js":"b459a8","SNB.lib.bundle/02.modernizr.js":"f634b5","SNB.lib.bundle/03.jquery.js":"53538f","SNB.lib.bundle/04.jquery.ui.js":"96c17c","SNB.lib.bundle/05.jquery.cookie.js":"68e2a4","SNB.lib.bundle/06.underscore.js":"d97ed3","SNB.lib.bundle/07.backbone.js":"8a9a44","SNB.lib.bundle/08.templates.js":"4aa7bf","SNB.lib.bundle/10.jade.runtime.js":"1fc7ae","SNB.lib.mobile/1.zepto.min.js":"acaeac","SNB.lib.mobile/2.underscore.js":"c2da07","SNB.lib.mobile/iscroll.js":"4a55be","bootstrap/bootstrap-alert.js":"a9f081","bootstrap/bootstrap-button.js":"ce03ae","bootstrap/bootstrap-carousel.js":"62b76a","bootstrap/bootstrap-collapse.js":"9be616","bootstrap/bootstrap-dropdown.js":"af96b6","bootstrap/bootstrap-modal.js":"cf302e","bootstrap/bootstrap-popover.js":"a4e6a7","bootstrap/bootstrap-scrollspy.js":"a88d39","bootstrap/bootstrap-tab.js":"8f2b45","bootstrap/bootstrap-tooltip.js":"682437","bootstrap/bootstrap-transition.js":"17fa23","bootstrap/bootstrap-typeahead.js":"97f107","common/SNB.helpers.js":"2bdc5e","common/backbone_1.1.2.js":"8531c9","common/css3-mediaqueries.js":"f83d37","common/fastclick.js":"753522","common/jquery-1.9.1.js":"b8b878","common/json.js":"b459a8","common/lib.js":"de2f7c","common/sea-2.3.0.js":"c823d9","common/sea.js":"24e81c","common/underscore_1.6.0.js":"3ffba8","common/util.js":"183faf","common/zepto-core-fx.1.1.3.js":"27e274","common/zepto-deferred.js":"977158","cube/cube_detail.js":"b26446","cube/cube_detail_m.js":"1ea5eb","cube/cube_discover.js":"b16cdd","cube/cube_discover_m.js":"b9ea8b","cube/cube_edit.js":"d058ee","cube/cube_guide.js":"88a7d5","cube/cube_recommend.js":"eb4aa8","cube/post_grid.js":"730811","cube/profile_cubes.js":"593e28","cube/range_slider.js":"358302","cube/stock_edit_modal.js":"9ad913","highcharts/jquery-1.6.4.min.js":"526f75","im2014/base.adapter.deliver.js":"17ba5b","im2014/base.adapter.js":"e895d8","im2014/base.config.js":"710ff1","im2014/base.js":"58869d","im2014/base.localstorage.js":"57720d","im2014/base.net.js":"540257","im2014/base.utils.js":"8cb3f7","im2014/db.contacts.js":"536985","im2014/db.groups.js":"aebe8f","im2014/db.js":"b1164d","im2014/db.message.helper.js":"0fa7e8","im2014/db.messages.js":"cd2db6","im2014/db.sessions.js":"b428e2","im2014/im.js":"3675e3","im2014/session.dialog.js":"34f336","im2014/session.editor.js":"fc99c9","im2014/session.gmm.js":"44c0a0","im2014/session.item.js":"2f722e","im2014/session.joingroup.js":"34f898","im2014/session.list.js":"35a7ff","im2014/session.message.js":"30b56c","im2014/session.setting.js":"a5fdcb","im2014/widget.emotion.js":"e07cbb","im2014/widget.joingroup.js":"b2ee4c","im2014/widget.requestjoingroup.js":"319aaa","im2014/widget.search.js":"2d2eda","im2014/widget.uploader.js":"e1abec","im2014/widget.viewer.js":"93c152","imeigu/xueqiu_popup.js":"61979d","lang/en.js":"c6550c","lang/zh-cn.js":"a606a6","lang/zh-tw.js":"4e0fdb","lib/autoresize.js":"f853a5","lib/chai.js":"a0130d","lib/jquery.easing.1.3.js":"008f85","lib/jquery.fullPage.js":"f69025","lib/mocha.js":"8799cd","lib/store.js":"9c7667","lib/ueditor.js":"2e0f51","lib/upload.js":"8837c4","pages/home.js":"1112bf","pages/single.js":"0a3e7d","widget/TSNB.addfriend.js":"f04fd7","widget/TSNB.addpdf.js":"d185b8","widget/TSNB.addstock.js":"0c459a","widget/TSNB.at.js":"a5ebeb","widget/TSNB.bindverify.js":"f3ea69","widget/TSNB.home-editor.js":"123ca2","widget/TSNB.newuser-guide.js":"3bc710","widget/TSNB.people-autocomplete.js":"92ed61","widget/TSNB.performance.js":"27b5e6","widget/TSNB.sharestatus.js":"16e249","widget/TSNB.stockalert.js":"1cb0fd","widget/TSNB.stockgroup.js":"7baec6","widget/TSNB.typeahead.js":"6e6634","widget/aside.js":"46008f","widget/backbone1.1.2.js":"181b4a","widget/bootstrap.js":"abac2a","widget/donate.js":"312591","widget/donate_tooltip.js":"435b5f","widget/editor.js":"25fcd3","widget/emotions.js":"623bc3","widget/favorite.js":"e356ee","widget/forward.js":"fb609b","widget/global_pin.js":"4c1878","widget/lodash.underscore.js":"1854ff","widget/profile_pin.js":"fb4311","widget/report_spam.js":"2e5e63","widget/repost_comment.js":"4bb3ae","widget/share.js":"6e71c0","widget/status.js":"d06d1e","widget/underscore1.6.0.js":"4d7fd6","widget/util.js":"c0629c","My97DatePicker/lang/en.js":"c6550c","My97DatePicker/lang/zh-cn.js":"a606a6","My97DatePicker/lang/zh-tw.js":"4e0fdb","bootstrap/tests/phantom.js":"e38dfa","bootstrap/tests/server.js":"21e92a","common/lib/jquery-1.9.1.js":"3dd6ee","common/lib/sea-2.3.0.js":"c823d9","common/lib/underscore_1.6.0.js":"834fa8","common/util/image.js":"73664d","common/util/jade.runtime.js":"aed6b5","common/util/jquery.extend.js":"cb4243","common/util/observer.js":"648151","common/util/password.js":"ef4528","common/util/upload.js":"8f1294","pages/about/app.js":"eecbff","pages/about/app_mobile.js":"7db607","pages/broker/TSNB.bind.js":"e8ed5d","pages/consultant/consultant-market.js":"2bc801","pages/event/TSNB.year-summary-mobile.js":"73f230","pages/event/TSNB.year-summary.js":"daff60","pages/event/cmc.js":"a7c273","pages/home/timeline.js":"1112bf","pages/invest/SNB.chart_base.js":"285f6f","pages/invest/SNB.fund_chart.js":"4a2cb1","pages/invest/SNB.mobile_chart.js":"bc032b","pages/invest/SNB.mobile_stock.js":"d942d7","pages/invest/SNB.profile_broker_rank.js":"85311d","pages/invest/SNB.rank.js":"677dd5","pages/invest/chart.js":"02e6ce","pages/pay/deposit-mobile.js":"799d95","pages/pay/deposit.js":"e37ac4","pages/pay/donate-mobile.js":"153feb","pages/pay/pin.js":"1804ea","pages/pay/subscribe-mobile.js":"c6187b","pages/pay/withdraw.js":"952521","pages/sns/index.js":"a6c885","pages/sns/single.js":"120bdc","pages/today/mobile.index.js":"f72378","pages/user/login.js":"ff5499","widget/aside/TSNB.ad.js":"55466e","widget/aside/TSNB.hot-stocks.js":"44327c","widget/aside/TSNB.interesting-people.js":"b01b82","widget/aside/TSNB.other-services.js":"70e391","widget/aside/TSNB.recommend-people.js":"7ddb30","widget/aside/TSNB.sysnotify.js":"e50d01","widget/aside/TSNB.today-talk.js":"8fa37c","widget/bootstrap/affix.js":"f014e8","widget/bootstrap/alert.js":"915f20","widget/bootstrap/bootstrap-datepicker.js":"daa8d6","widget/bootstrap/button.js":"3a8a2e","widget/bootstrap/carousel.js":"f763e0","widget/bootstrap/collapse.js":"c9ceab","widget/bootstrap/dropdown.js":"164604","widget/bootstrap/modal.js":"d390dd","widget/bootstrap/popover.js":"8c9993","widget/bootstrap/scrollspy.js":"37bd38","widget/bootstrap/tab.js":"5df6c4","widget/bootstrap/tooltip.js":"b973d7","widget/bootstrap/transition.js":"7af948","widget/bootstrap/typeahead.js":"1e1e67","widget/editor/at.js":"41b184","widget/editor/emotion.js":"bd52eb","widget/editor/umeditor.config.js":"ed3336","widget/editor/umeditor.js":"6b7121","widget/editor/zh-cn.js":"16b3e4","widget/flexpaper/flexpaper.js":"56a735","widget/flexpaper/flexpaper_handlers.js":"39b20d","widget/mobile/action.js":"43495d","widget/mobile/form.js":"03c77e","widget/mobile/modal.js":"309f6a","widget/mobile/overlay.js":"44e1eb","widget/status/comment.js":"239e91","widget/status/data.js":"d2678b","widget/status/pdf.js":"0af8cc","widget/status/pin.js":"4dce9c","widget/tmp/SNB.base.js":"73a62a","widget/tmp/json.js":"b459a8","widget/util/TSNB.donate.js":"dabf92","widget/util/areas.js":"4f6252","widget/util/modal.js":"0a947f","widget/util/notice.js":"c2c3a1","widget/util/share.js":"8c017a","widget/util/tooltip.js":"30a8e8","widget/util/typeahead.js":"f70471","widget/util/user.js":"9b9c3a","bootstrap/tests/unit/bootstrap-alert.js":"93d6ac","bootstrap/tests/unit/bootstrap-button.js":"996b53","bootstrap/tests/unit/bootstrap-carousel.js":"54a2cf","bootstrap/tests/unit/bootstrap-collapse.js":"1b1262","bootstrap/tests/unit/bootstrap-dropdown.js":"6a491c","bootstrap/tests/unit/bootstrap-modal.js":"6dd5a0","bootstrap/tests/unit/bootstrap-phantom.js":"940ffb","bootstrap/tests/unit/bootstrap-popover.js":"4f65eb","bootstrap/tests/unit/bootstrap-scrollspy.js":"bd7b2c","bootstrap/tests/unit/bootstrap-tab.js":"63f9fc","bootstrap/tests/unit/bootstrap-tooltip.js":"fc2c1c","bootstrap/tests/unit/bootstrap-transition.js":"a1b2cc","bootstrap/tests/unit/bootstrap-typeahead.js":"2f86e0","bootstrap/tests/vendor/jquery.js":"fcf997","bootstrap/tests/vendor/qunit.js":"a8c0db","pages/invest/chart/TSNB.chart.base.js":"33cd3a","pages/invest/chart/TSNB.chart.compare.js":"6b4c52","pages/invest/chart/TSNB.chart.event.js":"23af89","pages/invest/chart/TSNB.chart.kline.js":"3a1e79","pages/invest/chart/TSNB.chart.status.js":"62d5f1","pages/invest/chart/TSNB.chart.stock.js":"770897","pages/invest/chart/TSNB.chart.thumbnail.js":"52101d","pages/invest/hq/TSNB.compare_ah.js":"8dcaea","pages/invest/portfolio/TSNB.create-portfolio-group.js":"d9e67b","pages/invest/portfolio/TSNB.delete-portfolio-group.js":"af94fb","pages/invest/portfolio/TSNB.delete-portfolio.js":"1a6838","pages/invest/portfolio/TSNB.manage-portfolio-group.js":"1b0504","pages/invest/portfolio/TSNB.portfolio-util.js":"d78b8f","pages/invest/portfolio/TSNB.portfolio.js":"6580b6","pages/invest/portfolio/TSNB.stock-autocomplete.js":"cc5d2e","pages/sns/index/cube.js":"1f5d94","pages/sns/index/login.js":"665dd7","pages/sns/index/markets.js":"b51353","pages/sns/index/promotion.js":"aa01d3","pages/sns/index/stocks.js":"47fe9b"},
  cssVersion: {"about.css":"8a68c7","activate_bar.css":"90db89","bootstrap-lite.css":"09c973","bootstrap.css":"84b5ee","bootstrap_full.css":"66069a","bootstrap_tab_xueqiu.css":"69dee9","bootstrap_tab_xueqiu_white.css":"5492e5","button.css":"23513c","chart.css":"d41d8c","comment.css":"dbfbd5","connect_link.css":"0edf0b","default.css":"165b51","default_mobile.css":"264592","dh.css":"a34780","dialog.css":"828547","editor.css":"57d8ef","editor_inline.css":"7d7563","flexpaper.css":"ecc108","form.css":"c845bd","fullcalendar.css":"b1f726","guide_overlay.css":"9dd1cf","hots-statuses.css":"181d4e","icon.css":"680a07","im.css":"aa2f71","im2014.css":"dbd489","imgroup.css":"5445f8","jinNang.css":"4bd30a","jinnang_1394597838763.css":"4bd30a","jquery.tagsinput.css":"3f47e0","jquery.ui.css":"279647","mentions_block.css":"4b58aa","mocha.css":"a5dea9","mystatus.css":"272433","newChart.css":"5d9be9","pdfviewer.css":"720dd9","performance-year-mobile.css":"a17f1a","performance-year.css":"317994","performanceChart.css":"2589d4","personality-ie8.css":"6a37b0","personality.css":"c723c4","pop_login.css":"8f20df","portfolioIframe.css":"c85adf","portfolioNew.css":"4f2887","profile.css":"0737fc","profile_info.css":"4b5978","profile_operations.css":"a0abbd","profile_status.css":"01d683","pull-to-refresh.css":"3e5b69","searchBar.css":"aeef28","simplePagination.css":"b23401","snowbrick.css":"ccc31a","status_mobile.css":"4c93b3","status_operate_btn.css":"0872af","tab-setting.css":"506d45","today_topic.css":"a8f864","tooltip.css":"820355","uploadify.css":"d5b49f","userRecommend.css":"beabbe","user_list.css":"bb06fd","widget.css":"88e99b","widget_user.css":"d1e0c0","common/base.css":"2262f2","common/grid.css":"ad0354","common/iconfont.css":"5cf08f","common/layout.css":"746a95","common/menu.css":"985468","common/mobile.css":"3362b1","common/mod.css":"e27423","common/modal.css":"f9111d","common/nav-bar.css":"c37184","common/pager.css":"0d5b09","common/reset.css":"e2dffc","common/var.css":"d41d8c","cube/cube_card.css":"ae3e1a","cube/cube_detail.css":"d97083","cube/cube_detail_m.css":"9ac92d","cube/cube_discover.css":"30d439","cube/cube_discover_m.css":"d02a1d","cube/cube_edit.css":"f5208f","lib/jquery.fullPage.css":"3dfa38","pages/TSNB.about.css":"28449a","pages/home.css":"3ef6f1","pages/imeigu.css":"d51b5b","pages/post.css":"16fd7a","pages/profile.css":"093e27","pages/status.css":"cc43c8","pages/tip.css":"9bc5a0","touch/common.css":"1c57df","touch/normal.css":"d536b7","widget/TSNB.comment.css":"705fe6","widget/TSNB.donate.css":"708f8a","widget/TSNB.donate_tooltip.css":"672acf","widget/TSNB.performance.css":"588cce","widget/TSNB.portfolio_dialog.css":"68b2cb","widget/TSNB.portfolio_user_dialog.css":"9ad4f2","widget/TSNB.report_spam.css":"3e795c","widget/TSNB.share.css":"f36d77","widget/TSNB.status.css":"024cfd","widget/TSNB.user_dialog.css":"81075a","widget/btn.css":"9fdda0","widget/datepicker.css":"d683e7","widget/donate.css":"ab255d","widget/donate_tooltip.css":"9e0336","widget/global_pin.css":"92b1cf","widget/modal.css":"5fc4e9","widget/profile_pin.css":"60296d","common/css3/inline-block.css":"bb8c38","pages/about/animation.css":"1e4355","pages/about/app.css":"d919d8","pages/about/app_mobile.css":"5b4c12","pages/about/share.css":"6712c8","pages/consultant/consultant.css":"138686","pages/event/TSNB.year-summary-mobile.css":"864fa2","pages/event/TSNB.year-summary.css":"a868f5","pages/event/cmc-mobile.css":"7fe9f7","pages/event/cmc.css":"8d1acc","pages/home/home-editor.css":"a4a479","pages/home/newuser-guide.css":"23dd61","pages/home/widgets.css":"cfae61","pages/index/cube.css":"cc49b2","pages/index/default.css":"417e7b","pages/invest/dealList.css":"79d551","pages/invest/mobile_chart.css":"31d833","pages/invest/mobile_performance.css":"16e7bb","pages/invest/mobile_stock.css":"4a4c6d","pages/invest/profile_broker_rank.css":"55a18e","pages/invest/rank.css":"4d6196","pages/invest/stock_chart.css":"0eeda7","pages/mobile/common.css":"004801","pages/mobile/vars.css":"d41d8c","pages/pay/subscribe-mobile.css":"128827","pages/pay/wallet-mobile.css":"583bc0","pages/pay/wallet.css":"f7af19","pages/pin/pin-mobile.css":"bf2ba8","pages/sns/TSNB.single.css":"775597","pages/sns/home.css":"8f62db","pages/today/index-mobile.css":"a95cc9","pages/user/login.css":"ba73c8","widget/bootstrap/alerts.css":"2c520b","widget/bootstrap/badges.css":"da050d","widget/bootstrap/bootstrap.css":"971848","widget/bootstrap/breadcrumbs.css":"b9ab35","widget/bootstrap/button-groups.css":"a7c65b","widget/bootstrap/buttons.css":"a73cc0","widget/bootstrap/carousel.css":"93e128","widget/bootstrap/close.css":"30812b","widget/bootstrap/code.css":"fab06a","widget/bootstrap/component-animations.css":"63295e","widget/bootstrap/dropdowns.css":"d91661","widget/bootstrap/forms.css":"1dac09","widget/bootstrap/glyphicons.css":"024db0","widget/bootstrap/grid.css":"7f9bd0","widget/bootstrap/input-groups.css":"fc56c7","widget/bootstrap/jumbotron.css":"cf17ad","widget/bootstrap/labels.css":"3e0971","widget/bootstrap/list-group.css":"ec9751","widget/bootstrap/media.css":"ecbd91","widget/bootstrap/mixins.css":"a0cb66","widget/bootstrap/modals.css":"5b2682","widget/bootstrap/navbar.css":"abacbf","widget/bootstrap/navs.css":"9fbe5c","widget/bootstrap/normalize.css":"ddcb0b","widget/bootstrap/pager.css":"7be0a4","widget/bootstrap/pagination.css":"eaa566","widget/bootstrap/panels.css":"d53a2d","widget/bootstrap/popovers.css":"93bafa","widget/bootstrap/print.css":"b11602","widget/bootstrap/progress-bars.css":"580cf9","widget/bootstrap/responsive-embed.css":"1c5626","widget/bootstrap/responsive-utilities.css":"2db01f","widget/bootstrap/scaffolding.css":"0fc3a2","widget/bootstrap/tables.css":"462165","widget/bootstrap/theme.css":"52929d","widget/bootstrap/thumbnails.css":"b96eb4","widget/bootstrap/tooltip.css":"c060af","widget/bootstrap/type.css":"c8dff8","widget/bootstrap/utilities.css":"d3b1aa","widget/bootstrap/variables.css":"d41d8c","widget/bootstrap/wells.css":"578e1c","widget/mobile/modal.css":"f2f776","widget/mobile/normal.css":"d536b7","widget/mobile/top-bar.css":"f4eb52","widget/umeditor/editor.css":"5f1892","widget/umeditor/umeditor.css":"7eb569","widget/util/page.css":"3ea87c","pages/home/widgets/ad.css":"4f1e5e","pages/home/widgets/hot-stocks.css":"9c722b","pages/home/widgets/interesting-recommend.css":"25f080","pages/home/widgets/my-nav.css":"c4c64e","pages/home/widgets/other-services.css":"d76f0d","pages/home/widgets/sysnotify.css":"116c48","pages/invest/portfolio/group.css":"3e96d2","pages/invest/portfolio/portfolio.css":"f2f39b","widget/bootstrap/mixins/alerts.css":"d41d8c","widget/bootstrap/mixins/background-variant.css":"d41d8c","widget/bootstrap/mixins/border-radius.css":"d41d8c","widget/bootstrap/mixins/buttons.css":"d41d8c","widget/bootstrap/mixins/center-block.css":"d41d8c","widget/bootstrap/mixins/clearfix.css":"d41d8c","widget/bootstrap/mixins/forms.css":"d41d8c","widget/bootstrap/mixins/gradients.css":"d41d8c","widget/bootstrap/mixins/grid-framework.css":"d41d8c","widget/bootstrap/mixins/grid.css":"2f25b9","widget/bootstrap/mixins/hide-text.css":"d41d8c","widget/bootstrap/mixins/image.css":"d41d8c","widget/bootstrap/mixins/labels.css":"d41d8c","widget/bootstrap/mixins/list-group.css":"d41d8c","widget/bootstrap/mixins/nav-divider.css":"d41d8c","widget/bootstrap/mixins/nav-vertical-align.css":"d41d8c","widget/bootstrap/mixins/opacity.css":"d41d8c","widget/bootstrap/mixins/pagination.css":"d41d8c","widget/bootstrap/mixins/panels.css":"d41d8c","widget/bootstrap/mixins/progress-bar.css":"d41d8c","widget/bootstrap/mixins/reset-filter.css":"d41d8c","widget/bootstrap/mixins/resize.css":"d41d8c","widget/bootstrap/mixins/responsive-visibility.css":"d41d8c","widget/bootstrap/mixins/size.css":"d41d8c","widget/bootstrap/mixins/tab-focus.css":"d41d8c","widget/bootstrap/mixins/table-row.css":"d41d8c","widget/bootstrap/mixins/text-emphasis.css":"d41d8c","widget/bootstrap/mixins/text-overflow.css":"d41d8c","widget/bootstrap/mixins/vendor-prefixes.css":"d41d8c"},
  staticDomain: 'http://assets.imedao.com',
  bid : ''
});

SNB.data.access_token =  $.cookie("xq_a_token") || "7fd433866f17942022661a942c06f2b5fe387c88";
</script><!-- 防止局域网缓存用户信息--><script>(function(){
  var search = window.location.search || '';
  if (search.indexOf('_=') === -1 && SNB.bid !== '' && document.cookie && document.cookie.indexOf('bid=' + SNB.bid) === -1) {
    var searchArr = search.split('&');
    searchArr.push('_=' + (+new Date).toString(36));
    window.location.search = search.join('&');
  }
})();
</script><script src="http://assets.imedao.com/js/05.jquery.cookie.js"></script><script>function delCookie(name){//为了删除指定名称的cookie，可以将其过期时间设定为一个过去的时间
  var date = new Date();
  date.setTime(date.getTime() - 10000);
  document.cookie = name + '=a; expires=' + date.toGMTString();
}
/*
if(!$.cookie('xq_refresh') && $.cookie('xq_a_token')){
  $.ajax({
    url: '/user/refreshCookie',
    async: false
  }).done(function(){
    delCookie('xq_a_token');
    delCookie('xq_r_token');
    delCookie('xq_token_expire');
  });
}
*/
jQuery(function($){
  $('.navbar a.exit').on('click', function(){
    try{
      delCookie('xq_a_token');
      delCookie('xq_r_token');
      delCookie('xq_token_expire');
    } catch(e){
      console.log(e);
    }
  });
});</script><script src="http://assets.imedao.com/js/SNB.helpers-d5327e.js"></script><script>SNB.profileUser = {"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":130,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png!50x50.png","profile_image_url_small":"community/default/avatar.png!30x30.png"}</script><noscript><style>html {
  display: block
}</style><p class="ie6">当前浏览器禁用了JavaScript，导致不能正常使用雪球的功能，请打开JavaScript后再访问本站。</p></noscript><!--[if lt IE 8]><div class="ie6">你正在使用的浏览器版本过低（IE7或IE7以下，包括套用了IE内核的360浏览器、搜狗浏览器等）。<br />如果不能正常浏览本站或某些功能无法使用，请到微软官网下载升级 <a href="http://windows.microsoft.com/zh-CN/internet-explorer/downloads/ie">Internet Explorer</a> 或使用 <a href="http://www.google.com/chrome/">谷歌 Google Chrome</a> 浏览器。</div><![endif]--><div class="temp"></div><div class="navbar navbar-fixed-top"><div class="navbar-inner"><div class="container"><h1 id="logo"><a href="/"><img title="返回我的首页" src="http://assets.imedao.com/images/logo@2x.png" width="54px" height="30px" alt="雪球"></a></h1><div class="search"><form method="get" action="/k"><input id="quick-search" name="q" type="text" autocomplete="off" placeholder="搜索 股票/讨论/用户/群组" class="typeahead"></form><span class="icon"><i></i></span></div><ul class="nav pull-right account notlogined"><li><a href="/account/reg" class="reg">注册</a></li><li><a href="/" class="login">登录</a></li></ul></div></div></div><!--!=css('im.css')--><script>seajs.config({
  timeout: 60000,
  preload: [SNB.jsVersion && _.keys(SNB.jsVersion).length ? 'SNB.base-' + SNB.jsVersion['SNB.base.js'] + '.js' : 'SNB.base.js']
})
</script><script>seajs.use("SNB.guest.js")
</script><script>;(function () {
  var keys = _.keys(SNB.jsVersion)
    , map = [];
    
  if (keys.length) {
    _.each(keys, function(k) {
      var reg = new RegExp('\\/(' + k.replace(/\./g, '\\.') + ')(\\?.*|$)');
      
      map.push([reg, function (all, fileName, param) {
        var result = '/' + fileName.replace(/\.js$/i, '') + '-' + SNB.jsVersion[k] + '.js';
        
        if (param) {
          result += param;
        }
        
        return result;
      }]);
    });
    
    seajs.config({
      map: map
    });
  }
}())
</script><!-- test config--><script src="http://assets.imedao.com/js/bootstrap-6bd6fa.js"></script><div id="center" class="container"><div class="main"><div style="display:none" class="loading"></div><div class="wrapper"><link rel="stylesheet" href="http://assets.imedao.com/style/pages/profile-093e27.css"><div class="profile_box container "><div class="profile_box_behaviour"><div class="profile_box_operations"><div class="profile_operations"><ul class="operations relation"><li class="relationship"><span class="op addFriendBtn"><b>＋</b>加关注</span></li><li><a href="javascript:;" data-toggle="at" data-target="zangyn" class="at">@他</a></li><li><a href="javascript:;" class="block">拉黑</a></li><li><a href="javascript:;" class="reportSpam_user">举报</a></li></ul></div></div><div class="profile_box_users"><div style="display:none" class="usersList similarUser_list head-list"></div><script>seajs.use('SNB.similarUsers.js', function(){
  var collection=new SNB.Collections.similarUsers();
  collection.fetch({
    success:function(){
      var col_length = collection.length;
      if(col_length){
        var views=new SNB.Views.similarUsersList({el:$(".similarUser_list"),collection:collection});
        views.render();
        $(".similarUser_list").prepend("<h3>兴趣相近</h3>").show();
      }
    }
  })
})</script></div></div><div class="profile_box_info"><div class="profile_info"><div class="profile_info_pic"><img src="http://xavatar.imedao.com/community/201210/1352439404964-20121221.png!100x100.png" width="100" height="100"/></div><div class="profile_info_content"><h2><span>zangyn</span><a href="＃" style="display:none" data-user-id='6785033954' data-user-name="zangyn" class="setRemark">(备注)</a></h2><script>seajs.use("SNB.base.js", function(){
  SNB.get("/user/profile/show.json", {uid: SNB.profileUser.id, property: "card_sid,personality"}, function(data) {
    $(".profile_info_content h2").append("<a target='_blank' title='雪球名片' style='margin-left:6px' href='" + SNB.profileUser.profile + "/card'><img title='雪球名片' src='http://assets.imedao.com/images/card/" + (data[0]?'namecard-icon2.png':'namecard-icon2-gray.png') + "'/></a>")
    var p = data[1] && data[1].value != 'false';
    $(".profile_info_content h2").append("<a target='_blank' title='投资者性格" + (p ? '：' + SNB.Util.personalityResult(data[1].value) : '') + "' style='margin-left:6px' href='/event/personality/x/" + (SNB.profileUser.domain || SNB.profileUser.id) + "'><img title='投资者性格" + (p ? '：' + SNB.Util.personalityResult(data[1].value) : '') + "' src='http://assets.imedao.com/images/personality/icon_character" + (p ? '' : '_gray') + ".png'/></a>")
  })
})</script><ul><li class="gender_info"><span class="m head"></span>男&nbsp;&nbsp;&nbsp;海外澳大利亚&nbsp;&nbsp;&nbsp;</li><li>股票130只&nbsp;&nbsp;讨论7506条&nbsp;&nbsp;粉丝200896人</li><li><div class="item_title">能力圈：</div><div class="item_content discuss_stock_list"><span title="科大讯飞" class="discuss_stock">科大讯飞，</span><span title="中国平安" class="discuss_stock">中国平安，</span><span title="中信证券" class="discuss_stock">中信证券</span></div></li><li><div class="item_title">简介：</div><div class="item_content expend_in_oneline"><p class="summary">如果不上雪球，你就输在了投资的起跑线上。</p><p style="display:none" class="detail">如果不上雪球，你就输在了投资的起跑线上。<span class="fold_all">收起<i class="newIcon_expend"></i></span></p></div></li></ul></div></div><script>seajs.use("SNB.base.js", function(){
  SNB.get("/account/oauth/user/show.json",{source:"sina",userid:SNB.profileUser.id},function(ret){
    if(ret && ret.id){
      $(".profile_info").find("ul li").eq(0).append("<a href='http://weibo.com/"+ret.id+"' target='_blank'><span class='newIcon newIcon_weibo'>&nbsp;</span> 微博</a>")
    }
  })
  $(".show_all,.fold_all").on("click",function(e){
    e.preventDefault();
    var that = this;
    $(that).closest(".expend_in_oneline").find("p").toggle();
  })
})</script></div></div><link rel="stylesheet" href="http://assets.imedao.com/style/pages/invest/profile_broker_rank-55a18e.css"><div class="rank-container"><div class="rank-groups newtab"><ul class="nav nav-tabs rank-tabs"></ul><span class="desc">每天的数据将于第二个交易日13:00前更新，由用户及<a href="http://bj.cgws.com/Default.jsp" target="_blank">长城证券</a>授权提供。</span><a href="http://xueqiu.com/3945550771/31966036" class="link">榜单说明</a><a href="http://xueqiu.com/event/rank/gws" class="link">看看其他人</a></div><div class="rank-wrapper"><div class="rank-performance"><div class="performance-title"><span class="title">账户收益</span></div><div class="performance-chart"><div class="performance-info"><div class="performance-income"><div id="pchart"></div><div class="performance-rate"><p class="desc">参赛后的收益率</p><p class="income"> </p><p class="time">参赛时间：-</p><div class="rank-stocks"><p><span class="title">持股前五：</span></p></div></div></div><div class="rank-hold"><div class="rank-day-rate"><p class="data">-</p><p class="desc">日收益</p></div><div class="rank-assets"><p class="data">-</p><p class="desc">净资产</p></div><div class="rank-marketValue"><p class="data">-</p><p class="desc">总市值</p></div><div class="rank-rate"><p class="data">-</p><p class="desc">持仓比例</p></div></div></div></div></div><div class="rank-chart"><div id="capitalReturnRateChartContainer" class="chartContainer"><div class="noData"><span>请您在券商处同步盈亏，或券商暂未支持同步。 </span></div><div class="head"><h3> <a href="/performance">收益率</a></h3><span class="timeInterval"></span><span class="dropdown"><span>业绩对比</span><span class="caret"></span></span></div><div id="ROAStateInfo" class="stateInfo"><span class="stockInfo"><span class="sign"></span><span class="stockName">盈亏 </span><span class="stockUp"></span></span><div class="loadState">数据载入中    </div></div><div id="capitalReturnRateChart"></div><div class="chartInfo"><ul class="selectTime"><li id="1m" class="selected">1月</li><li id="3m">3月</li><li id="6m">6月</li><li id="1y">1年</li><li id="3y">3年</li><li id="5y">5年</li><li id="all">全部</li></ul><span class="info">仅自己可见</span></div><div id="popCompare"><div class="popLeft"><label class="checkbox"> <input type="checkbox" symbol="SH000001"/>上证指数</label><label class="checkbox"> <input type="checkbox" symbol="SZ399001"/>深证指数</label><label class="checkbox"> <input type="checkbox" symbol="HKHSI"/>恒生指数</label><label class="checkbox"> <input type="checkbox" symbol="SP500"/>标准普尔500指数</label><label class="checkbox"> <input type="checkbox" symbol="NASDAQ"/>纳斯达克指数</label><label class="checkbox"> <input type="checkbox" symbol="DJI30"/>道琼斯指数</label><label class="checkbox"> <input type="checkbox" symbol="ICS30"/>i美股中概30指数</label><label class="checkbox"> <input type="checkbox" symbol=""/><input id="searchCompareStock" type="input" placeholder="股票名称/代码"/></label></div><div class="popRight"></div><div class="popClose"><button class="btn">关闭</button></div></div></div><div class="rank-industry"><div class="industry-title">行业分布</div><div class="industry-chart"></div></div></div><div class="rank-tran">   <div class="tran-title"><span class="title">交易历史</span><a href="#" class="show-trans">交易<span class="tran-num"></span>笔，点击查看</a></div><div class="tran-list"></div><div class="hide-tran-list"><a href="#">收起</a></div></div><div class="rank-status"><div class="status-title"><span class="title">关于"百度(BIDU)的讨论"</span><a href="#" class="back-trans">返回交易历史</a></div><div class="tran-status-list"></div></div></div></div><script src="http://assets.imedao.com/js/pages/invest/SNB.profile_broker_rank-85311d.js"></script><style>.cube-follow {
  text-decoration: none;
  cursor: pointer;
}

.cube-follow span {
  display: none;
  width: 20px;
  height: 12px;
  margin:0 3px;
}

.cube-follow-false .add {
  display: inline-block;
  background: url(http://assets.imedao.com/images/profile_cube_image.png) no-repeat -18px -1px;
}

.cube-follow-true .del {
  display: inline-block;
  background: url(http://assets.imedao.com/images/profile_cube_image.png) no-repeat  0px -1px;
}

a.rebalance {

  display: inline-block;
  background: url(http://assets.imedao.com/images/profile_cube_image.png) no-repeat -60px 0px;
  width: 20px;
  height: 12px;
}
a.contact{
  background: url(http://assets.imedao.com/images/profile_cube_image.png) no-repeat -40px 0px;
  display: inline-block;
  width: 20px;
  height: 12px;
}
.limit{
  background: none!important;
  width: auto!important;
  margin: 0!important;
  
}
.moreC{
  background: none;
  border: none;
  color: #0055A2;
  cursor: pointer;
  height: 20px;
  line-height: 20px;
  margin: 0;
  padding: 5px 6px 5px 15px;
  text-align: right;
  border-top: 1px solid #DDD;
}
.none{
  padding: 15px;
  font-size: 14px;
  text-align: center;
  color: #aaa;
}

</style><div class="profile-cube-list portfolioContainer"><div class="cube-title newtab"><ul style="float:left;display:block" class="nav nav-tabs"><li class="active"><a class="nav nav-tabs">他创建的组合(<i class="num">--</i>)</a></li></ul><div class="clear"></div></div><div class="tableContainer"><table><thead><tr><th>组合</th><th>最新净值</th><th>总收益</th><th width="87px">操作</th></tr></thead><tbody><tr><td colspan="4"><div class="loading"></div></td></tr></tbody></table></div></div><script>$.ajax({
  url:"/cubes/count_limit.json",
  data:{
    user_id:SNB.profileUser.id
  },
  type:"get"
}).success(function(data){
  $('.profile-cube-list .cube-title .num').text(data.exists_count);
  $('.profile-cube-list .cube-title .limit').text(data.allow_count);
  
})
seajs.use('cube/profile_cubes.js');
</script><div class="portfolioContainer"><div class="newtab"><ul id="portfolioTab" class="nav nav-tabs"></ul><div class="clear"></div></div><div class="tableContainer"><table class="portfolioNew"><thead><tr><th style="min-width:120px;">股票</th><th style="min-width:40px;">当前价 </th><th style="min-width:80px;">买入目标价</th><th style="min-width:80px;">卖出目标价</th><th>备注</th></tr></thead><tbody><tr><td colspan="7"><div class="loading"></div></td></tr></tbody></table></div></div><script src="http://assets.imedao.com/js/jquery.mousewheel-41ebd2.js"></script><script src="http://assets.imedao.com/js/raphael-ea1c64.js"></script><script>seajs.use('SNB.dialog.js')
seajs.use(['SNB.newChart.js', 'SNB.portfolioNew.js'],function(_c, p){
  var portfolio=new p.Portfolio();
})</script><div class="status_box "><div class="statuses_tab newtab"><ul class="nav nav-tabs"><li id="statusMenu" class="dropdown active status_tab"><a href="#status_content" data-target="#statusMenu" data-type="" data-toggle="dropdown" data-text="主贴(7506)">主贴<b class="caret"></b></a><ul class="dropdown-menu"><li><a href="#status_content" data-toggle="tab" data-type="" data-text="主贴">主贴</a></li><li><a href="#status_content" data-toggle="tab" data-type="0" data-text="原发布">原发布</a></li><li><a href="#status_content" data-toggle="tab" data-type="1" data-text="带标题">带标题</a></li><li><a href="#status_content" data-toggle="tab" data-type="2" data-text="长文章">长文章</a></li><li><a href="#status_content" data-toggle="tab" data-type="3" data-text="交易">交易</a></li></ul></li><li><a href="#favs_content" data-toggle="tab">收藏<small id="favsCount"></small></a></li><li><a href="#friends_content" data-toggle="tab">关注(647)</a></li><li><a href="#followers_content" data-toggle="tab">粉丝(200896)</a></li></ul></div><div class="statuses_container container tab-content"><div id="status_content" class="status_content container active tab-pane"><div class="status_bd"><div id="statusLists" class="allStatuses no-head"></div></div><div class="status_widget"><div class="seachbar"><input id="searchStatus" type="text" autocomplete="off" placeholder="搜索他的讨论" class="placeholder"/><span class="glass"><i></i></span></div><style>.mentionedStocks{
  margin-top:15px;
  display:none;
}
.stocksList{
  border-top:1px solid #F1F1F1;
  margin-top: 8px;
  padding-top: 10px;
  font-size:12px;
}
.stocksList .stockInfo{
  display:inline-block;
  margin-right:5px;
  margin-bottom:8px;
}
.stocksList .stockInfo span{
  color:#888;
  cursor:pointer;
}
</style><div class="mentionedStocks"><h2 class="widget-title">他经常讨论的股票 </h2><div class="fixit"></div><div class="stocksList"></div><div class="fixit"></div><script>seajs.use("SNB.base.js", function(){
  var uid = 6785033954;
  SNB.get("/user/top_status_count_stock.json", { count: 5, uid: uid }, function(stocks){
    if ( stocks && stocks.length ) {
      var html = "";
      _.each(stocks, function(stock, index){
        if ( stock.status_all_count > 0 ) {
          var count = stock.status_all_count,
            name = stock.stockName,
            symbol = stock.symbol,
            title = name + "(" + symbol + ") 查看" + count + "条讨论";
            
          html += '<span class="stockInfo" title="' + title + '" data-name="' + name + '" data-symbol="' + symbol + '" data-count="' + count + '"><a href="#">' + name + '</a><span>(<span class="status_count">' + count + '</span>条讨论)</span></span>';
        }
      });
      if ( html ) {
        $(".mentionedStocks .stocksList").append(html);
        $(".mentionedStocks").show();
      }
    }
  })
})</script></div></div></div><div id="favs_content" class="fade tab-pane"></div><div id="friends_content" class="fade tab-pane"></div><div id="followers_content" class="fade tab-pane"></div></div><style>.seachbar .glass {
  padding:0;
}
.seachbar .glass i{
  background-position:-172px -1px
}</style><script>(function($){
  SNB.data.req_isBrick = 0;
  SNB.data.statuses = {"total":7504,"maxPage":376,"count":20,"statuses":[{"id":22862638,"user_id":6785033954,"title":"贵州茅台2012年第四季度部分基金持股清单","created_at":1358601750000,"retweet_count":0,"reply_count":0,"fav_count":1,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"国联安双禧中证100 416,722 富兰克林国海收益149,810 富兰克林国海沪深300 60,105 富兰克林国海研究精选58,000 长信恒利优势股票型基金26,959 富国通胀通缩主题轮动股票型基金73,900 富国上证综指交易型开放式指数基金联接基金200 长盛沪深300指数基金(LOF)14,523 东方核心动力股票型开放式基金33,...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862638","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":694,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 21:22","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"国联安双禧中证100 &nbsp;416,722<br>富兰克林国海收益149,810<br>富兰克林国海沪深300 &nbsp;60,105<br>富兰克林国海研究精选58,000<br>长信恒利优势股票型基金26,959<br>富国通胀通缩主题轮动股票型基金73,900<br>富国上证综指交易型开放式指数基金联接基金200<br>长盛沪深300指数基金(LOF)14,523<br>东方核心动力股票型开放式基金33,138<br>长盛同庆中证800指数分级基金274,320<br>广发沪深300指数基金268,724<br>光大保德信红利股票型基金540,962<br>广发大盘成长混合型基金2,087,000","source":"雪球"},{"id":22862593,"user_id":6785033954,"title":"中信国健EHS体系获得认证，为安全环保生产保驾护航","created_at":1358601041000,"retweet_count":1,"reply_count":0,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://www.cpgj-pharm.com/html/news/20130118/news11020130118111524.html\" title=\"http://www.cpgj-pharm.com/html/news/20130118/news11020130118111524.html\"  target=\"_blank\">http://www.cpgj-pharm.com/html/news/20130118/news11020130118111524.html</a> 中信国健EHS体系经过一年努力，顺利通过英国标准协会上海分支机构（BSI）审核认证，取得《ISO14001:2004》及《OHSAS18001:2007》证书，现场评审获得审核单位的高度认可。 作为国内抗体药物领先企业，公司高度重视安全生...","type":"3","source_link":null,"edited_at":null,"pic":"http://xqimg.imedao.com/13c52ee2513873fca0478522.jpg!thumb.jpg,http://xqimg.imedao.com/13c52ee252f893fdcda53cde.jpg!thumb.jpg","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862593","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":542,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 21:10","expend":true,"canEdit":true,"firstImg":"http://xqimg.imedao.com/13c52ee2513873fca0478522.jpg!thumb.jpg","topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://www.cpgj-pharm.com/html/news/20130118/news11020130118111524.html\" title=\"http://www.cpgj-pharm.com/html/news/20130118/news11020130118111524.html\"  target=\"_blank\">http://www.cpgj-pharm.com/html/news/20130118/news11020130118111524.html</a><br>中信国健EHS体系经过一年努力，顺利通过英国标准协会上海分支机构（BSI）审核认证，取得《ISO14001:2004》及《OHSAS18001:2007》证书，现场评审获得审核单位的高度认可。<br><br>作为国内抗体药物领先企业，公司高度重视安全生产及环境保护。“EHS”管理体系按照“PDCA”模式开展，在全公司各部门的积极配合及高层领导的支持指导下，各部门全员参与，精诚协作。由公司高层领导的EHS体系推进小组严格按照体系要求，扎实推进，取得了阶段性成功。<br><br>通过认证、获得证书只是我们的起点，2013年我们将继续深入推进EHS工作，同时将各项制度落地实施，用行动来推动EHS绩效，实现持续改善，跟上公司发展步伐，更好地为安全生产保驾护航。<br><br><img class=\"ke_img\" src=\"http://xqimg.imedao.com/13c52ee2513873fca0478522.jpg!custom.jpg\" /><br><br><img class=\"ke_img\" src=\"http://xqimg.imedao.com/13c52ee252f893fdcda53cde.jpg!custom.jpg\" /><br><br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ISO14001:2004 &nbsp;585625 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OHSAS18001:2007","source":"雪球"},{"id":22862263,"user_id":6785033954,"title":"格力电器2012年第四季度部分基金持仓清单","created_at":1358597071000,"retweet_count":0,"reply_count":0,"fav_count":1,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"国泰事件驱动股票240,000 国投瑞银瑞福进取12,783,234 富兰克林国海弹性市值4,507,873 富兰克林国海收益600,000 富兰克林国海研究精选500,000 长信内需成长股票型基金125,542 东吴深证100指数增强型(LOF)基金269,816 广发深证100指数分级基金394,528 广发内需增长灵活配置混合型基金8,500,000 广发...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862263","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":599,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 20:04","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"国泰事件驱动股票240,000<br>国投瑞银瑞福进取12,783,234<br>富兰克林国海弹性市值4,507,873<br>富兰克林国海收益600,000<br>富兰克林国海研究精选500,000<br>长信内需成长股票型基金125,542<br>东吴深证100指数增强型(LOF)基金269,816<br>广发深证100指数分级基金394,528<br>广发内需增长灵活配置混合型基金8,500,000<br>广发消费品精选股票型基金299,930<br>广发聚丰股票型基金31,349,333<br>广发小盘成长股票型基金(LOF)17,635,250<br>广发聚富开放式基金12,755,145<br>广发策略优选混合型基金15,019,858<br>大成价值增长证券投资基金7,000,000<br>国泰事件驱动策略股票型证券投资基金240,000<br>长盛成长价值证券投资基金638,990<br>光大保德信动态优选灵活配置混合型证券投资基金170,000<br>广发聚富开放式证券投资基金12,755,145<br>富兰克林国海中国收益证券投资基金600,000","source":"雪球"},{"id":22862237,"user_id":6785033954,"title":"科大讯飞2012年第四季度部分基金持仓清单","created_at":1358596634000,"retweet_count":0,"reply_count":15,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"富兰克林国海收益1,244,988 富兰克林国海研究精选499,957 广发中小板300交易型开放式指数基金267,508 东吴中证新兴产业指数基金406,481 广发中证500指数基金(LOF)676,626 宝盈核心优势灵活配置混合型基金250,000 长信双利优选灵活配置混合型基金389,000 国投瑞银瑞和沪深300指数分级证券投资基金93...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862237","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":882,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 19:57","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"富兰克林国海收益1,244,988<br>富兰克林国海研究精选499,957<br>广发中小板300交易型开放式指数基金267,508<br>东吴中证新兴产业指数基金406,481<br>广发中证500指数基金(LOF)676,626<br>宝盈核心优势灵活配置混合型基金250,000<br>长信双利优选灵活配置混合型基金389,000<br>国投瑞银瑞和沪深300指数分级证券投资基金93，075<br>广发中证500指数证券投资基金(LOF)676,626<br>长盛同辉深证100等权重指数分级证券投资基金92,395<br>富国高新技术产业股票型证券投资基金140,326<br>宝盈泛沿海区域增长股票证券投资基金2,397,550<br>长信双利优选灵活配置混合型证券投资基金389,000<br>富兰克林国海研究精选股票型证券投资基金499,957<br>富兰克林国海中国收益证券投资基金1,244,988<br>瑞和300 &nbsp;&nbsp;&nbsp;93,075","source":"雪球"},{"id":22862212,"user_id":6785033954,"title":"长城汽车2012年第四季度部分基金持仓清单","created_at":1358596138000,"retweet_count":0,"reply_count":0,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"长盛同禧信用增利债券型基金10,000 财通价值动量混合型基金387,608 东吴进取策略灵活配置混合型开放式基金1,274,944","type":"1","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862212","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":699,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 19:48","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"长盛同禧信用增利债券型基金10,000<br>财通价值动量混合型基金387,608<br>东吴进取策略灵活配置混合型开放式基金1,274,944","source":"雪球"},{"id":22862204,"user_id":6785033954,"title":"云南白药2012年第四季度部分基金持仓清单","created_at":1358596018000,"retweet_count":0,"reply_count":0,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"富国通胀通缩主题轮动股票型基金297,687 长盛同鑫保本混合型基金10,000 东方核心动力股票型开放式基金70,300 长信增利动态策略股票型基金919,926 广发稳健增长开放式基金2,784,678 大成蓝筹稳健基金8,014,699","type":"1","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862204","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":558,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 19:46","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"富国通胀通缩主题轮动股票型基金297,687<br>长盛同鑫保本混合型基金10,000<br>东方核心动力股票型开放式基金70,300<br>长信增利动态策略股票型基金919,926<br>广发稳健增长开放式基金2,784,678<br>大成蓝筹稳健基金8,014,699","source":"雪球"},{"id":22862191,"user_id":6785033954,"title":"民生银行2012年第四季度部分基金持仓清单","created_at":1358595771000,"retweet_count":0,"reply_count":0,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"国联安双禧中证100 26,719,156 国联安主题1,200,000 富兰克林国海沪深300 4,750,000 富兰克林国海深化价值10,747,389","type":"1","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862191","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":679,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 19:42","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"国联安双禧中证100 &nbsp;&nbsp;&nbsp;26,719,156<br>国联安主题1,200,000<br>富兰克林国海沪深300 4,750,000<br>富兰克林国海深化价值10,747,389","source":"雪球"},{"id":22862182,"user_id":6785033954,"title":"人福医药2012年第四季度部分基金持仓清单","created_at":1358595607000,"retweet_count":2,"reply_count":5,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"国投瑞银成长优选2,245,824 广发中证500指数基金(LOF)883,042 长城久富核心成长股票型证券投资基金(LOF)3，250，000 长城久富核心成长股票型证券投资基金(LOF)80,000 博时新兴成长股票型证券投资基金12,132,707 工银瑞信睿智中证500指数分级证券投资基金36,448","type":"1","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862182","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":834,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 19:40","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"国投瑞银成长优选2,245,824<br>广发中证500指数基金(LOF)883,042<br>长城久富核心成长股票型证券投资基金(LOF)3，250，000<br>长城久富核心成长股票型证券投资基金(LOF)80,000<br>博时新兴成长股票型证券投资基金12,132,707<br>工银瑞信睿智中证500指数分级证券投资基金36,448","source":"雪球"},{"id":22862063,"user_id":6785033954,"title":"天士力2012年第四季度报告部分基金持股清单","created_at":1358593176000,"retweet_count":0,"reply_count":0,"fav_count":1,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"基金名称 持股数量 国泰事件驱动股票 130,882 东吴价值成长双动力 2,411,784 东吴中证新兴产业指数基金 127,309 广发核心精选股票型基金 2,170,315 广发小盘成长股票型基金(LOF) 7,800,000 广发聚富开放式基金 4,142,690 东吴价值成长双动力股票型基金 2,411,784","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862063","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":605,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 18:59","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"基金名称 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;持股数量<br><br>国泰事件驱动股票 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;130,882<br><br>东吴价值成长双动力 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,411,784<br><br>东吴中证新兴产业指数基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;127,309<br><br>广发核心精选股票型基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,170,315<br><br>广发小盘成长股票型基金(LOF) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7,800,000<br><br>广发聚富开放式基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,142,690<br><br>东吴价值成长双动力股票型基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,411,784","source":"雪球"},{"id":22862022,"user_id":6785033954,"title":"QFII求变欲进军中小市值股瑞士信贷看涨至2600点","created_at":1358592532000,"retweet_count":5,"reply_count":1,"fav_count":9,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"QFII这一外来和尚一向被认为是成熟的价值投资者。但因市场鲜有公开资料，QFII机构一直笼罩着神秘面纱。 从上市公司中，可以略窥QFII操作策略一二。青睐大盘蓝筹，选绩优龙头，长期持有。这样的操作策略使得其2007年大获全胜、2008年神奇抗跌跑赢大盘。 然而理柏监测的数据显示，QFII基金近三年来净...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862022","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":972,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 18:48","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"QFII这一外来和尚一向被认为是成熟的价值投资者。但因市场鲜有公开资料，QFII机构一直笼罩着神秘面纱。<br><br>　　从上市公司中，可以略窥QFII操作策略一二。青睐大盘蓝筹，选绩优龙头，长期持有。这样的操作策略使得其2007年大获全胜、2008年神奇抗跌跑赢大盘。<br><br>　　然而理柏监测的数据显示，QFII基金近三年来净值平均下跌28.09%。其中跌幅最为严重者为荷兰安智银行股份有限公司旗下ING ChinaA share Fund II class J，跌幅达36.45%。截至去年11底，该基金大跌48.90%，不过该基金在2012年的最后一个月，净值大涨20.64%，但想要力挽狂澜弥补损失仍不可能。<br><br>　　QFII不能死守大盘蓝筹股<br><br>　　2003年QFII进军A股市场以来，其操作思路就带有独特的烙印，主力品种主要集中在绩优大盘股和行业龙头股之上，并且换手率很低。翻阅上市公司的前十大流通股可以发现，近年来QFII持仓重点为银行、家电、钢铁等，几乎清一色白马股。“QFII比较重视资产配置，注重板块之间的配置，不会单押某个板块，分布比较均衡。远离小型股，由于小型股容易操纵，流动性较大，在市场波动比较大时容易出问题。”理柏(Lipper)亚洲区研究总监冯志源曾分析QFII投资理念。<br><br>　　这种投资理念曾经为QFII带来不俗业绩，2007年，大盘上涨96.66%，QFII持有重仓股当年平均上涨186.56%，跑赢大盘89.9个百分点。这或许与前一年QFII重仓股的滞涨有关。2008年大熊市中，QFII所持重仓股再度跑赢大盘6个百分点，在熊市中表现出抗跌的特质。2009年同样表现不俗，跑赢大盘。<br><br>　　然而，2010年以来，QFII命运陡转。三年的熊市，让QFII损失惨重。<br><br>　　统计2010年1月1日至2012年12月31日的数据显示，QFII平均跌幅超过28%，同期，国内A股基金平均跌幅为19%。<br><br>　　掌舵QFII投资的新加坡富敦投资总监孟宁告诉记者：“QFII这三年来确实做得不好，这和市场环境有关，大盘蓝筹股和中小盘股呈现了冰火两重天的境遇。”<br><br>　　同时，他表示，QFII不能再死守大盘蓝筹股。<br><br>　　“配备一个投资经理，坐在美国的办公室看中国市场的研报，配置些大盘蓝筹股，这样的QFII是不太可能做好A股市场的。现在不少QFII也认为这几年业绩确实不好，有些QFII机构开始拿出一部分额度，交给国内的机构来操作。” 孟宁告诉记者。<br><br>　　而一位国内基金公司的国际投资部人士告诉记者，现在也有QFII机构不再一味坚持把境外市场的投资理念搬到A股市场上来，很多的QFII自己也在国内组建了团队。<br><br>　　孟宁表示，目前中国市场结构悄然生变，投资理念和投资方法也随之而变化。“我所了解到的是，确实是有QFII机构专门研究成长股，而且只做中小盘，虽然中小上市公司会隐含问题，但在一定程度上代表了真正的经济增长方向。不过，类似于此的QFII机构是少数”。<br><br>　　亦有负责QFII投资人士告诉记者，以前小市值公司基本不在研究范围之内，不过，最近也有20亿市值左右的公司被纳入研究标的。但20亿市值以下的公司仍不覆盖。但进军中小市值股票，这仍仅仅是少数QFII的想法。<br><br>　　长期跟踪QFII的理柏亚洲区研究总监冯志源告诉记者，经历过三年的熊市之后，市场也会发生变化，之前是中小盘股涨势淋漓，未来市场是不一样的。大盘蓝筹股会受到市场的青睐。也只有大盘蓝筹是最有可能带动市场继续上行的，“大多数QFII机构仍旧会按照既有理念来操作，不会因为市场涨跌而改变理念”。<br><br>　　A股预计有12%-23%潜在涨幅<br><br>　　苦熬三年之久的QFII基金终于在2012年最后一个月收益颇丰。如今，大盘在2300点展开争夺战。在这关键时刻，QFII仍在积极看多。<br><br>　　手握5亿美元外汇额度的QFII机构瑞士信贷认为，未来12个月，上证指数有可能上涨至2600点，预计有12%-23%的潜在涨幅。<br><br>　　在回复记者的采访中，瑞士信贷表示，中国宏观稳定趋势将会持续。过去数月数据显示中国稳定和稳步复苏的趋势将会延续。在需求变量中，基础设施投资增长保持强劲势头，仍是增长的关键驱动力。另一方面，投资和零售业也显示出复苏的迹象。<br><br>　　同时瑞士信贷认为，改革引导全局。政府落实更全面的经济改革的决定是可能影响市场的一个重要因素。若该决定成为现实，投资者可对中国长期增长的前景抱更大的信心，这反过来，也是一个对市场发展的积极信号。<br><br>　　冯志源则告诉记者：“从目前的市场情况来看，今年很有可能会终结过去三年熊市的表现，当然还是有待观察的，目前来讲，大盘是有一个比较强劲的弹升，我觉得如果能够在这个位置稳定下来，再加上未来企业的财报表现，加上总体经济的改善，我觉得今年对于上证会有比较大的上升空间。”<br><br>　　此外，冯志源表示，目前A股还有很多资金并未进场，比如散户资金。在和QFII机构交流中，大多数仍旧是看好A股市场，<br><br>　　掌舵淡马锡一部分QFII额度的投资经理孟宁认为，具体到投资策略，本身投资而言应该采取自下而上的方式选股，但是鉴于机构资金只能选择自上而下的投资方法，先判断宏观经济并以此决定股票仓位。<br><br>　　然而，QFII投资A股市场时候所要求的仓位底线是90%，这就意味着只有10%的仓位选择空间。<br><br>　　“去年下半年，我一直觉得宏观经济形势不容乐观，仓位一直保持在90%，由于仓位限制，尽力而为也只能做到如此。选仓位后，再根据整个经济形势进行板块的配置，比如去年我就觉得周期类股票不会有出彩表现，所以就将煤炭股抛售，从而选择具有安全边际的消费类股票。行业之后是选股，由于投资A股市场团队有限，我更加倾向于选择一些我相对来说比较了解、基本面比较稳定的个股。具体来看行业里的前几名，业绩比较好，属于龙头白马，应该不会有大的投资风险。”孟宁告知记者。<br><br>　　去年底之前，孟宁基本上配置的都是银行，“彼时，我认为几乎所有的行业基本面都非常差，只有银行相对比较安全。此外，配置了一些长期成长性的股票，例如大消费，包括酒、医药都是长期持有的，一些产能过剩的行业比如煤炭，则是短期波段性地配置，工业制造类的已经基本上全部抛弃了。”<br><br>　　然而，去年12月份金融股已经大涨一波，是否会获利了结离场，孟宁告诉记者边走边看，要看利率市场化改革、银行监管政策等。(《21世纪经济报道》)<br><br>　　部分QFII去年三季度持仓情况<br><br>　　比尔及梅林达盖茨信托基金会 　　瑞士联合银行集团<br><br>　　代码 名称 持仓数量 占流通股 　　代码 名称 持仓数量 占流通股<br><br>　　(万股) 比例(%) 　　(万股) 比例(%)<br><br>　　000065.SZ 北方国际 150.0160 0.92 　　000651.SZ 格力电器 4,172.0198 1.41<br><br>　　000488.SZ 晨鸣纸业 2,370.1666 2.92 　　000822.SZ 山东海化 209.0500 0.23<br><br>　　000932.SZ 华菱钢铁 929.8175 0.38 　　600009.SH 上海机场 1,752.8691 1.60<br><br>　　300347.SZ 泰格医药 27.1041 2.02 　　600104.SH 上汽集团 5,004.1166 0.55<br><br>　　600031.SH 三一重工 2,000.0723 0.28 　　600456.SH 宝钛股份 94.6000 0.42<br><br>　　600161.SH 天坛生物 439.9996 0.90 　　600519.SH 贵州茅台 385.9469 0.37<br><br>　　600218.SH 全柴动力 350.0141 1.24 　　600585.SH 海螺水泥 2,541.6384 0.64<br><br>　　600486.SH 扬农化工 284.1801 1.65 　　600588.SH 用友软件 1,684.5015 1.72<br><br>　　600517.SH 置信电气 600.0000 0.97 　　600660.SH 福耀玻璃 2,786.7262 1.42<br><br>　　600550.SH 天威保变 350.8529 0.26 　　600993.SH 马应龙 453.9026 1.37<br><br>　　600552.SH 方兴科技 300.0330 2.56 　　601186.SH 中国铁建 6,882.0692 0.69<br><br>　　600588.SH 用友软件 1,288.5386 1.32 　　002228.SZ 合兴包装 425.6910 1.23<br><br>　　600598.SH 北大荒 1,000.0210 0.56 　　002342.SZ 巨力索具 181.8335 0.87<br><br>　　600651.SH 飞乐音响 1,200.0540 1.62 　　002595.SZ 豪迈科技 236.8835 3.66<br><br>　　600655.SH 豫园商城 1,333.9156 0.93 　　600588.SH 用友软件 2,120.4622 2.17<br><br>　　601390.SH 中国中铁 2,500.0090 0.15 　　601186.SH 中国铁建 3,235.2293 0.32<br><br>　　601390.SH 中国中铁 2,378.1935 0.14<br><br>　　挪威中央银行 　　601766.SH 中国南车 3,475.2518 0.37<br><br>　　000155.SZ *ST川化 191.7100 0.41 　　601800.SH 中国交建 1,930.7572 1.66<br><br>　　000420.SZ *ST吉纤 278.4009 0.87 　　<br><br>　　000698.SZ 沈阳化工 168.5970 0.27 　　摩根大通银行<br><br>　　000707.SZ 双环科技 117.9900 0.25 　　000789.SZ 江西水泥 980.4883 2.48<br><br>　　000818.SZ 方大化工 223.7378 0.54 　　000822.SZ 山东海化 268.9300 0.30<br><br>　　000859.SZ 国风塑业 174.3520 0.41 　　300155.SZ 安居宝 18.2480 0.41<br><br>　　000949.SZ 新乡化纤 317.7184 0.38 　　300176.SZ 鸿特精密 14.1500 0.55<br><br>　　000951.SZ 中国重汽 63.7900 0.15 　　600066.SH 宇通客车 753.3772 1.12<br><br>　　000973.SZ 佛塑科技 202.3389 0.26 　　600229.SH 青岛碱业 239.9148 0.61<br><br>　　002111.SZ 威海广泰 76.4286 0.42 　　600674.SH 川投能源 1,411.0807 1.10<br><br>　　002211.SZ 宏达新材 124.9410 0.47 　　600801.SH 华新水泥 662.3854 1.38<br><br>　　002221.SZ 东华能源 119.9738 0.54 　　600897.SH 厦门空港 302.3565 1.02<br><br>　　002277.SZ 友阿股份 493.5323 0.88 　　<br><br>　　002307.SZ 北新路桥 91.6970 0.45 　　高盛集团<br><br>　　002308.SZ 威创股份 131.1674 0.68 　　002301.SZ 齐心文具 852.0319 5.66<br><br>　　002448.SZ 中原内配 99.9752 1.75 　　600004.SH 白云机场 1,573.6754 1.37<br><br>　　600075.SH 新疆天业 112.4600 0.26 　　600161.SH 天坛生物 350.0745 0.72<br><br>　　600117.SH 西宁特钢 194.9974 0.26 　　600270.SH 外运发展 271.3994 0.82<br><br>　　600172.SH 黄河旋风 327.5491 0.66 　　600377.SH 宁沪高速 1,819.4837 0.48<br><br>　　600239.SH 云南城投 708.4266 1.13 　　600897.SH 厦门空港 239.9867 0.81<br><br>　　600270.SH 外运发展 235.3026 0.71 　　601186.SH 中国铁建 6,113.1229 0.61<br><br>　　600299.SH 蓝星新材 133.8000 0.26 　　601800.SH 中国交建 4,271.6953 3.67<br><br>　　600311.SH 荣华实业 224.0909 0.34 　　<br><br>　　600339.SH 天利高新 149.1540 0.26 　　哥伦比亚大学<br><br>　　600531.SH 豫光金铅 65.7566 0.22 　　002661.SZ 克明面业 38.5518 1.86<br><br>　　600601.SH 方正科技 355.9470 0.16 　　002687.SZ 乔治白 49.9918 2.03<br><br>　　600697.SH 欧亚集团 344.9337 2.22 　　300005.SZ 探路者 483.9362 3.18<br><br>　　600776.SH 东方通信 132.1800 0.14 　　300336.SZ 新文化 100.0000 4.17<br><br>　　600797.SH 浙大网新 182.8000 0.22 　　300337.SZ 银邦股份 60.1068 1.28<br><br>　　600101.SH 明星电力 299.9895 0.93<br><br>　　美林国际 　　600305.SH 恒顺醋业 367.6000 2.89<br><br>　　000651.SZ 格力电器 5,147.3324 1.74 　　600355.SH 精伦电子 283.5858 1.15<br><br>　　000895.SZ 双汇发展 537.4368 0.89 　　600543.SH 莫高股份 123.4552 0.38<br><br>　　600007.SH 中国国贸 1,042.5502 1.04 　　600594.SH 益佰制药 682.6315 1.94<br><br>　　600361.SH 华联综超 1,024.1519 2.11 　　600826.SH 兰生股份 413.5309 0.98<br><br>　　600377.SH 宁沪高速 757.6567 0.20 　　<br><br>　　600585.SH 海螺水泥 2,911.2645 0.73 　　摩根士丹利<br><br>　　600779.SH 水井坊 297.6311 1.01 　　000002.SZ 万科A 7,986.7736 0.83<br><br>　　600887.SH 伊利股份 2,240.4121 1.41 　　000488.SZ 晨鸣纸业 545.9125 0.67<br><br>　　601186.SH 中国铁建 6,892.9187 0.69 　　000651.SZ 格力电器 6,577.5865 2.22<br><br>　　601800.SH 中国交建 2,948.2581 2.53 　　002511.SZ 中顺洁柔 197.1627 2.09<br><br>　　600519.SH 贵州茅台 556.4397 0.54<br><br>　　601006.SH 大秦铁路 8,105.9658 0.55<br><br>　　000759.SZ 中百集团 1,511.7987 2.22<br><br>　　300170.SZ 汉得信息 301.0426 2.93<br><br>　　600219.SH 南山铝业 797.3010 0.41<br><br>　　600377.SH 宁沪高速 1,734.3034 0.46<br><br>　　（来源：WIND资讯）","source":"雪球"},{"id":22862014,"user_id":6785033954,"title":"片仔癀2012年第四季度部分基金持股清单","created_at":1358592392000,"retweet_count":0,"reply_count":3,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"基金名称 持股数量 富国通胀通缩主题轮动股票型基金 189,725 东吴中证新兴产业指数基金 106,674 广发中证500指数基金(LOF) 156,566 中证500沪市交易型开放式指数基金 6,642 国投瑞银融华债券型证券投资基金 289,407 工银瑞信睿智中证500指数分级证券投资基金 6,481","type":"3","source_link":null,"edited_at":1358593139000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22862014","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":574,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 18:46","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"基金名称 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;持股数量<br><br><br>富国通胀通缩主题轮动股票型基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;189,725<br><br>东吴中证新兴产业指数基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;106,674<br><br>广发中证500指数基金(LOF) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;156,566<br><br>中证500沪市交易型开放式指数基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6,642<br><br>国投瑞银融华债券型证券投资基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;289,407<br><br>工银瑞信睿智中证500指数分级证券投资基金 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6,481","source":"雪球"},{"id":22860607,"user_id":6785033954,"title":"关于片仔癀系列产品网络市场整顿的通知","created_at":1358570730000,"retweet_count":2,"reply_count":4,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":" ","type":"1","source_link":null,"edited_at":null,"pic":"http://xqimg.imedao.com/13c511f3d065e3fea7bb2414.jpg!thumb.jpg,http://xqimg.imedao.com/13c511f5605483fe75a25384.jpg!thumb.jpg,http://xqimg.imedao.com/13c511f74e34a3fdf5e24d1d.jpg!thumb.jpg","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22860607","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":627,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 12:45","expend":true,"canEdit":true,"firstImg":"http://xqimg.imedao.com/13c511f3d065e3fea7bb2414.jpg!thumb.jpg","topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<img class=\"ke_img\" src=\"http://xqimg.imedao.com/13c511f3d065e3fea7bb2414.jpg!custom.jpg\" /><br><img class=\"ke_img\" src=\"http://xqimg.imedao.com/13c511f5605483fe75a25384.jpg!custom.jpg\" /><br><img class=\"ke_img\" src=\"http://xqimg.imedao.com/13c511f74e34a3fdf5e24d1d.jpg!custom.jpg\" />","source":"雪球"},{"id":22860595,"user_id":6785033954,"title":"","created_at":1358570535000,"retweet_count":0,"reply_count":0,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600436\"   target=\"_blank\">$片仔癀(SH600436)$</a> 片仔癀官方旗舰店搞得确实不错，自明朝而生，成就百年佳礼，有点深度，有点味道。 ","type":"0","source_link":null,"edited_at":null,"pic":"http://xqimg.imedao.com/13c51142561443fd7981827f.jpg!thumb.jpg,http://xqimg.imedao.com/13c51144117463fd125502ee.jpg!thumb.jpg,http://xqimg.imedao.com/13c511457d85c3fa3e888097.jpg!thumb.jpg","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22860595","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":476,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-19 12:42","expend":true,"canEdit":true,"firstImg":"http://xqimg.imedao.com/13c51142561443fd7981827f.jpg!thumb.jpg","topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600436\"   target=\"_blank\">$片仔癀(SH600436)$</a> 片仔癀官方旗舰店搞得确实不错，自明朝而生，成就百年佳礼，有点深度，有点味道。<img class=\"ke_img\" src=\"http://xqimg.imedao.com/13c51142561443fd7981827f.jpg!custom.jpg\" /><br><img class=\"ke_img\" src=\"http://xqimg.imedao.com/13c51144117463fd125502ee.jpg!custom.jpg\" /><br><img class=\"ke_img\" src=\"http://xqimg.imedao.com/13c511457d85c3fa3e888097.jpg!custom.jpg\" />","source":"雪球"},{"id":22845281,"user_id":6785033954,"title":"","created_at":1358399417000,"retweet_count":0,"reply_count":3,"fav_count":1,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"<a href=\"http://xueqiu.com/S/SH600436\"   target=\"_blank\">$片仔癀(SH600436)$</a> 网购的片仔癀产品今天中午才收到，试了下炫莹药香型的牙膏，有种草药的味道，感觉比云南白药的牙膏要好一些，可能是心理作用吧，冻干全草是个好东西，菇精糖片也不错。其它的用了再说。","type":"0","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22845281","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":492,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-17 13:10","expend":false,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"<a href=\"http://xueqiu.com/S/SH600436\"   target=\"_blank\">$片仔癀(SH600436)$</a> 网购的片仔癀产品今天中午才收到，试了下炫莹药香型的牙膏，有种草药的味道，感觉比云南白药的牙膏要好一些，可能是心理作用吧，冻干全草是个好东西，菇精糖片也不错。其它的用了再说。","source":"雪球"},{"id":22844623,"user_id":6785033954,"title":"绝地屠杀，别忘记那些挫骨扬灰的痛苦！叶荣添","created_at":1358394187000,"retweet_count":2,"reply_count":10,"fav_count":4,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"叶荣添的话你可以当做儿戏，那么资金的成交就是实实在在的事实。到了现在这个地步我已经没有任何顾忌了，我就是拿命都必须把你的手摁住不让你买，否则你们必定将用难以忍受的巨痛来反省自己的狂妄和自满，我除了用挫骨扬灰来表达我的忧虑之外，甚至诛灭九族这样的言语都无法表达我的担心。短短两天...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22844623","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":740,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-17 11:43","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"叶荣添的话你可以当做儿戏，那么资金的成交就是实实在在的事实。到了现在这个地步我已经没有任何顾忌了，我就是拿命都必须把你的手摁住不让你买，否则你们必定将用难以忍受的巨痛来反省自己的狂妄和自满，我除了用挫骨扬灰来表达我的忧虑之外，甚至诛灭九族这样的言语都无法表达我的担心。短短两天之内在指数看似没有下跌的情况下，资金就悄悄的大幅净流出达到201亿的巨量，难道你还不明白是怎么回事吗？我们什么时候见过大盘在短短48小时之内能流出过这么大的资金？是，仅仅只有3478的那一次而已。除此之外，就算是08年1月初暴跌和2010年11月3186这两次也都没有超过百亿的资金。现在，放在你们眼前的只有两条路，投降或者被屠杀！<br><br> &nbsp;&nbsp;只有这两种结果能诠释什么叫做雪崩，见顶的征兆已经从之前有无数个蓝筹股提前于大盘见顶转变为了市场开始用最大的权重工行和石油来抗住指数来掩饰个股资金的出逃，今天的下跌虽然指数只是仅仅下跌16个点，但是盘中的那一次却深深的透露出了因此的杀机。无论是力度还是速度，都在预示着一场恐怖的突然暴跌就要来临，在速度和力度已经具备的时候只差幅度了，下跌的幅度取决于最近消息面的好坏，这个时候只要一有风吹草动大盘就会如惊弓之鸟般换不择路，你们可以看看在今天下午那一次下跌的时候，不仅仅有力度和速度，资金在短短12分钟之内就大幅逃走48亿完全可以证明这不是开玩笑，而在这48亿的巨量逃走资金中民生银行，深发展等是绝对的杀跌主力，虽然收盘依然回归平静但这种假象只能蒙蔽那些不懂运作的散户和一些小机构。在这些中小资金看来他们渴望得到的是调整后再上扬，那么从表象上就给他这个结局，于是，从工行最后10分钟的大单护盘行为中也就满足了这种需求，那些在两点之前甚为恐慌的人们在最后半小时又冲了进去。但是这一次，他们却再难以出来。<br><br> &nbsp;&nbsp;&nbsp;利用郭树清主席QFII增加十倍拉上去指数刚刚一天过后，郭树清就再次用上市公司还太少来回应疯狂上涨是不理智的行为，中日问题的再次升级也为日后的变盘提供了支撑。大盘现在的核心在我看来就是茅台和平安在引导着中国股市，因为茅台代表着的是中国最大的利益共同集团，这个集团里面有政府，民企，行贿，腐败，政治，权势个人，上市公司等的综合规律，他的股价直接反应了场外群里的命运，茅台的低迷直接说明了当前支持中国股市上涨缺乏实际支撑，中国平安则是在茅台反应了场外这些群里命运之后，关乎到他们利益的场内资金动向。自从茅台爆出塑化剂和限酒令后实际上表明的是过去中国政治和企业的运作模式将被推翻，需要一个时间来反应和过度。这必将影响到以茅台为首的这类国有大企业的业绩和命运，也因此他的股价的好坏提前预示了股市的最终走向，换句话说就是在多数人现在认为的牛市里面，如果指数能达到2500点，那么茅台必将创造历史新高。而这样的思维逻辑是和政治指导思想所不相符了，这也是牛市论是做梦的原因。如果茅台的股价在还没有完成改革之前就再次创造了历史新高，那新领导层上台后的这些改革思想和实干兴邦不是被市场当做放屁了吗？<br><br> &nbsp;&nbsp;中国股市是个讲故事的地方，但任何的小说都必须有实际原型作为参照物而改编不能单靠想象杜撰，这个参照物的好坏决定了小说的品质和读者的数量。如果没有好的编剧和参照物，那么无论表演者有多么好的口才最终都将沦为空谈误国，而这个参照物就是：业绩！只有实实在在的业绩才是真正讲好故事的题材，很快你们就会看到一个个这些上市公司在年报的打击下原形毕露！<br><br> &nbsp;&nbsp;大盘在2200你举棋不定可以同情，那么2300如果看不清事实就是自己欺骗自己。我上次说过下跌不需要警惕因为这是必将发生的事实谁也改变不了，真正需要警惕是连续性的大跌可能在短短几天之内就将市场完全打回原形，这种下跌和疯狂上涨最大的不同就是上涨给你时间去思考下一步怎么办，而这种下跌通常你都不敢再看电脑一眼。你不要以为几十点的上涨很疯狂很痛快，更疯狂的是一根超过一百点的大跌阴线，连续几次放在你面前到时候你可能都不敢打开你的账户。你们是我这么多年来出生入死的好兄弟，不要再掩耳盗铃了。我只希望，在绝地屠杀的到来前你们能为自己的老婆，孩子，父母想想，一旦空军到来不会像叶荣添这般仁慈的和你讲理，到时候恐怕将会是万念俱灰，玉石俱焚，生灵涂炭啊！走人吧兄弟们我真的是为你们好，不要犹豫。第一步，我们先2159见！晚安！<br><br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;我是真的付出我的爱 &nbsp;&nbsp;黑暗骑士叶荣添","source":"雪球"},{"id":22843115,"user_id":6785033954,"title":"美国六大名校成QFII  哥伦比亚大学钟情兰生股份","created_at":1358384288000,"retweet_count":8,"reply_count":1,"fav_count":8,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"证监会披露的最新QFII(合格境外机构投资者)名录显示，去年共有72家QFII获批，是前年29家的近2.5倍。其中去年12月有6家QFII获批。这样，截止到去年底，QFII总数已达到207家。 在香港举行的亚洲金融论坛上，中国证监会主席郭树清表示，目前RQFII及QFII占A股市场比例很小，可能只有1.5%至1.6%的比例，...","type":"3","source_link":null,"edited_at":1358384380000,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22843115","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":755,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-17 08:58","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"证监会披露的最新QFII(合格境外机构投资者)名录显示，去年共有72家QFII获批，是前年29家的近2.5倍。其中去年12月有6家QFII获批。这样，截止到去年底，QFII总数已达到207家。<br><br>　　在香港举行的亚洲金融论坛上，中国证监会主席郭树清表示，目前RQFII及QFII占A股市场比例很小，可能只有1.5%至1.6%的比例，未来QFII、RQFII总额度将有计划地持续增加，让QFII、RQFII占A股市值比例扩大9至10倍。<br><br>　　美国大学十大名校<br><br>　　六家成了QFII<br><br>　　去年12月份获批的6家QFII中，有5家注册地在香港，1家注册地在台湾。值得注意的是，中信证券国际投资管理(香港)、易方达资产管理(香港)、华夏基金(香港)均是内地的基金公司在香港设立的子公司，如今又以QFII的身份“杀”回A股市场。<br><br>　　QFII中，金融机构和投资机构占了绝大多数。金融机构中，瑞士银行、德意志银行、法国兴业银行、巴克莱银行、渣打银行、摩根大通银行、富通银行以及美林国际、高盛等金融大鳄纷纷在列，去年又有台湾的全球人寿保险、国泰人寿保险、南山人寿保险，以及中银集团人寿保险、瑞士盈丰银行、澳大利亚的麦格理银行等加入。<br><br>　　记者查阅QFII名单发现，到目前为止，曾被列为美国十大名校的10所著名大学中，已有6所进入QFII行列。其中杜克大学是在去年9月获批QFII资格。在杜克大学之前，耶鲁大学和斯坦福大学于2006年获批，哥伦比亚大学和哈佛大学于2008年获批，普林斯顿大学于2011年11月获批。<br><br>　　截至14日，沪深总市值约23.7万亿元人民币，按1.5%至1.6%的比例计算，当前QFII及RQFII在A股市场的投资额约3500至3800亿元人民币，如果按QFII、RQFII占A股市值比例扩大9至10倍，未来被允许通过QFII及RQFII渠道投资A股的外资规模有望达3万亿至4万亿元人民币。<br><br>　　去年4月初，证监会宣布新增QFII额度500亿美元，同时新增RQFII额度500亿元人民币。这样，RQFII累计总额度达到700亿元，QFII的总额度则达到800亿美元。国家外汇管理局最新公布的数据显示，截至去年底，外管局累计批准QFII投资额度374.43亿美元，距离800亿美元的上限还有较大距离。<br><br>　　耶鲁钟情二线蓝筹<br><br>　　哥伦比亚大学爱买新股<br><br>　　美国很多著名大学都是私立学校。私立学校的主要资金来源就是捐赠资金，用捐赠资金投资理财。如哈佛大学的捐赠基金由哈佛管理公司运作，背靠哈佛，有着最好的人才来源，他们资金的运作回报较高，资金总额从1990年的48亿美元涨到2008年6月30日的369亿美元。资料显示，这些有美国名校背景的QFII大多喜欢长期持股，青睐的个股却各有不同。如耶鲁大学偏爱二线蓝筹。哥伦比亚大学则偏爱中小盘股，包括中小板和创业板个股。<br><br>　　以耶鲁大学为例，同花顺iFinD统计显示，到去年三季度末，其共持有中国国贸、伊利股份、云南白药、格力电器、双汇发展5只个股。2011年三季度，耶鲁大学买入中国国贸，此后连续两个季度增持。去年中国国贸股价累计涨幅27.81%，表现强于大盘。而耶鲁大学在伊利股份、云南白药和格力电器上面的投资收益也均不菲。<br><br>　　哥伦比亚大学的投资则相对分散，而且喜欢买新股。iFinD统计显示，去年以来哥伦比亚大学曾先后出击15只个股，其中沪市8只，分别是明星电力、秦岭水泥、恒顺醋业、精伦电子、莫高股份、益佰制药、兰生股份、九州通；深市中小板3只，分别是卡奴迪路、克明面业、乔治白；创业板4只，分别是探路者、永清环保、新文化和银邦股份。<br><br>　　创业板的新文化、银邦股份以及中小板的乔治白去年7月份才上市，但三季度哥伦比亚大学便大举买入，其中新文化还是第一大流通股东；永清环保也是上市不久哥伦比亚大学便成了第一大流通股东。<br><br>　　比较成功的是对探路者的投资，2010年三季度买入后，四季度和2011年一季度继续增持，去年二季度、三季度股价达到历史高点附近时大幅减持，估计收益在50%以上。<br><br>浙江在线-钱江晚报","source":"雪球"},{"id":22842989,"user_id":6785033954,"title":"抗癌概念股——抗癌受益股","created_at":1358382828000,"retweet_count":7,"reply_count":1,"fav_count":24,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"政策背景： 据央视消息，记者今日从卫生部了解到，2013年，我国农村医疗保障重点将向大病转移。包括儿童白血病、先心病、末期肾病、乳腺癌、宫颈癌、重性精神疾病、耐药肺结核、艾滋病机会性感染、血友病、慢性粒细胞白血病、唇腭裂、肺癌、食道癌、胃癌、I型糖尿病、甲亢、急性心肌梗塞、脑梗死、...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22842989","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":3080,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-17 08:33","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"政策背景：<br><br>据央视消息，记者今日从卫生部了解到，2013年，我国农村医疗保障重点将向大病转移。包括儿童白血病、先心病、末期肾病、乳腺癌、宫颈癌、重性精神疾病、耐药肺结核、艾滋病机会性感染、血友病、慢性粒细胞白血病、唇腭裂、肺癌、食道癌、胃癌、I型糖尿病、甲亢、急性心肌梗塞、脑梗死、结肠癌、直肠癌等20种疾病全部纳入大病保障范畴，报销比例不低于90%。新农合人均筹资水平将达到340元左右，新农合资金总额增加到2700亿，一些农村地区的大病患者已经成为受益者。<br><br>以下个股仅供参考，是否介入，何时介入，大家则根据自己经验考虑多方因素，尤其是明日大盘走势，明日大盘将有可能是面临调整的转折点！<br><br>1.兰太实业（600328）盐藻是抗癌第一绿色环保药<br><br>1831年，“盐藻”第一次被法国生物学家杜纳尔在死海周边正式发现（因此被国际命名为“杜氏盐藻”【Dunaliella salina】），杜纳尔一定想不到，当今世界对盐藻的关注程度不亚于对核武器的重视！<br><br>盐藻诞生于38亿年前，是地球上最古老的单细胞生物，可在＋53℃酷暑中存活、-27℃严寒中下繁衍，0.9％的盐水即可杀灭细菌，盐藻却可以在96％的盐水中生生不息，历经五次生物大灭绝而不死，生命力非常顽强，积蓄了人体必需的所有营养元素，这就奠定了盐藻对于治疗各种疾病的基本要素。 从1986年开始，以色列魏茨曼研究所联合国内四家医疗机构联合进行盐藻临床实验，发现盐藻可以作用于人体各处所有病变。值得一提的是，1986年前苏联切尔诺贝利核事故发生后，709名受灾儿童被送入耶鲁撒冷医院，医生给他们服用三个月的盐藻，然后间断三个月，如此反复，两年后，孩子们体内放射性危害物质完全被清除，牛皮癣以及流泪症状完全消失。<br><br>目前，审查最严格的FDA（美国食品药物管理局英文缩写）已经将盐藻列为OTC药品，即非处方药，用于心脑血管、肝、胰腺、胃、眼病、颈部以上癌症等疾病的临床治疗。2011年，日本核泄漏时，一粒盐藻药物被炒到8美元，而且还要优先供应给政府机构和科研人员，普通民众只能通过地下交易获得少量盐藻，据说最终价格被抬高10倍不止。奥运会游泳冠军马克8226;施皮茨、马拉松女皇保拉8226;拉德克里夫、20世纪最杰出女运动员杰西8226;乔伊娜-柯西，均认为长期服用盐藻是他们夺冠的法宝。随着神奇的盐藻一步步被解密，人们对盐藻的应用越来越广泛，临床医疗、卫生保健、食品，世界盐藻之父阿莫兹教授预言：人类健康正在进入盐藻时代。<br><br>2011年2月，盐藻已通过审查最严格的FDA（美国食品药物管理局英文缩写）认证。在国内，吉兰泰盐藻更是被联合国评价为最好的盐藻。产品通过FDA认证，说明该产品的安全性和有效性是确切的，可以合法进入欧美市场。在美国，盐藻早已作为药物通过FDA认证，被列为OTC药品，即非处方药，用于心脑血管、肝、胰腺、胃、眼病、颈部以上癌症等疾病的临床治疗。特别值得一提的是，美国癌症协会推荐的癌症首选治疗方案是：病人在接受放疗和化疗时，医生给病人服用一定剂量盐藻，一方面保护正常细胞免受侵害，抑制细胞活跃性变异，并可降低癌症转移和复发机率。可以说，美国人癌症治愈率远远高出中国，盐藻是最大的功臣。<br><br>鉴于盐藻在健康领域的卓越表现，联合国开发计划署向全世界大力推广盐藻。在中国，联合国开发计划署与国内某研发机构设立专项进行养殖应用等研究，遗憾的是因不具备天然无污染的养殖环境致使项目终止。<br><br>吉兰泰盐湖，位于内蒙古自治区阿拉善高原，人迹罕至的大漠造就了它纯天然、无污染的独特优势，湖区气候干燥，最高气温40.9℃，最低气温-32.2℃，年温差和日温差都很大；年平均降水量115mm，年蒸发量3036mm，兰太药业在此建成了18万平方米的盐藻养殖池，是目前国内最大，世界最佳的盐藻养殖培育基地，年产20万吨优质盐藻粉。经科学检测：吉兰泰盐藻β-胡萝卜素的含量是其它盐藻的2.8倍，维生素E是5倍，进入人体可形成更多RXR和RAR的结合体。<br><br>2.海欣股份(600851)<br><br>公司控股子公司海欣生物技术与上海第二军医大学合作研发的“抗原致敏的人树突状细胞”(APDC)，可用于治疗直肠癌，是我国首个自主研发的获得国家食品药品监督管理局正式批准的、针对晚期大肠癌的APDC治疗性疫苗。目前，肠癌药物市场广大，光是几个主要国家的抗大肠癌药物市场容量就在17亿美元以上，估计抗癌药物的利润率能达到80%以上。<br><br>3.江苏吴中(600200)<br><br>控股子公司江苏吴中医药集团有限公司与江苏省科学技术厅签署关于《江苏省科技成果转化专项资金项目合同》，公司在研“国家一类生物抗癌新药重组人血管内皮抑素注射液获得的研发与产业化”项目获得了江苏省科技成果转化专项资金扶持。资料显示，重组人血管内皮抑素注射液为国家一类生物抗癌新药，具有自主知识产权，2006年曾获国家“863”项目支持，用于非小细胞肺癌。目前该项目处于申请三期临床研究阶段，此次项目资金的获取将为该项目的三期临床研究工作和今后的产业化提供重要的资金保证。<br><br>4.华神集团（000790）<br><br>公司生产销售的的治疗肝癌新药碘[131Ⅰ]美妥昔单抗注射液（利卡汀），是全球第一个用于治疗原发性肝癌的药物，也是我国第一个具有自主知识产权的抗体类药物。该药于2005年取得新药证书后，2007年通过了国家药监局GMP认证，获准正式应用于临床治疗。2007年7月7日，上海市第十人民医院（同济大学附属第十人民医院）的专家采用利卡汀成功地为三名晚期肝癌患者实施了单克隆抗体导向载体治疗，标志着利卡汀由临床研究阶段正式进入临床应用阶段。<br><br>5.丰原药业（000153）<br><br>公司与中人科技合资的丰原中人药业（公司占60%股权）保证顺铂植入剂抗癌新药在2012年9月底前上市；公司大力投入癌症辅助治疗新药研发工作。<br><br>6.南京医药（600713）<br><br>南京医药获得抗癌特效药里葆多全国独家经销权<br><br>7.康恩贝(000572)<br><br>康恩贝与美国凯德药业拟成立合资公司，开发α胎蛋白用于肝癌的治疗性疫苗药物项目，公司以现金出资占七成股权。该药物在美国已经通过FDA相关审评，目前正在美国进行Ⅰ期临床试验。<br><br>8.普洛股份(000739)<br><br>公司研发的癌症基因靶向诊断试剂具有高壁垒特性。资料显示，该项目是采用人类遗传基因组学技术锁定癌症靶点，用克隆蛋白或是天然蛋白作为探针，携带造影剂，以针剂的形式注射到人体内。可作为确认癌细胞的大小及是否需要用药物治疗的依据。普洛股份独家生产的百士欣是国家二类抗癌新药。目前，百士欣已成了浙江省内县一级及以上医院，以及广东、北京、江苏等省市大医院治疗癌症的首选药物，年销售额达到了8000多万元。<br><br>9.四环生物(000518)<br><br>公司主要产品包括一类抗癌新药注射用重组人白介素-2，用于肾癌、恶性黑色素瘤以及其他恶性肿瘤综合治疗。<br><br>10.美罗药业（600297）<br><br>仿制药股，受益药品专利集中到期及受日本地震提振。<br><br>11.兰生股份（600826）<br><br>单克隆抗体技术，公司参股34.65%兰生国健药业与中信泰富共同投资成立“上海中信国健药业有限公司”，兰生国健占41.69%，公司占0.73%。08年中信国健研制的生物新药“益赛普”(注射用重组人11型肿瘤坏死因子受体-抗体融合蛋白)荣获国家科学技术发明奖二等奖，是我国第一个真正实现产业化并上市销售的人源化单克隆抗体类药物。已完成4条750升细胞培养生产线建设并顺利投产，年生产能力达到毫克级装药量400万支。<br><br>12.华北制药（600812）<br><br>公司抗癌药进入第二期临床试验（根据公司的产品发展规划，结合迁建和新园区建设的需要，以及公司的技术储备等情况，公司拟实施一类抗癌新药合作项目,该项目为合作方的原研发产品，并已获得两项国家发明专利授权。该项目总投资10800万元，计划分两期实施：一期内容为2010年12月前分阶段投资3500万元，独家受让该产品的临床批件、专利和粘细菌技术平台等，同时投资1500万元合作完成Ⅲ期临床试验，合计投资5000万元；二期项目为产业化工程建设期，拟根据一期项目进展情况，待时机成熟后双方成立合资公司，公司以投资方式入股，占65%的股份，转让方以技术方式入股，占35%的股份。同时进行生产场地规划及设施建设，通过GMP验收，取得生产批件，并完成IV期临床试验，计划于2011年5月实现规模化生产，预计投资5800万元。工程建设期为1年，项目建成后第3年预计可实现销售收入1.8亿元）<br><br>13.海正药业（600267）<br><br>公司是盐酸表柔笔星和奥沙利铂的抗生素类抗肿瘤药龙头，他克莫司作为首仿药在欧洲上市，将给公司带来不菲的收益；后续还有大量仿制药将在美国上市，有望重演Ranbaxy在1999-2004 年的高成长历程。制剂出口驱动的高速增长，将给投资者带来丰厚的回报。<br><br>14.长春高新（000661）<br><br>公司今年上市的Tα1市场潜力国家一类新药，该产品的氨基酸序列与生物活性与国外化学合成品完全一致。由于该项目的开发技术难度高，到目前为止，国内、国外都没有基因重组的Tα1上市。胸腺素α1在临床上的应用主要有三方面：<br><br>（1） 病毒性传染病的治疗，对乙型肝炎、丙型肝炎的疗效尤为突出；<br><br>（2） 肺癌及黑色素瘤等一些恶性肿瘤的治疗；<br><br>（3） 机体免疫机能的增强等。可形成45亿元人民币的销售市场<br><br>15.恒瑞医药（600276）<br><br>公司单一对映体的手性药物—左亚叶酸钙可用于增强5-氟尿嘧啶的抗肿瘤活性，主要治疗骨肉瘤经大剂量甲氨蝶呤治疗后与叶酸拮抗相关的症状和结肠癌、肾癌；公司多种抗肿瘤药品在国内排名第一。公司生产的替吉奥胶囊是一种氟尿嘧啶衍生物口服抗癌剂，它包括替加氟（FT）和吉美嘧啶（CDHP）及奥替拉西（Oxo）两类调节剂，用于治疗胃癌、直肠癌、头颈部癌、非小细胞肺癌、转移性乳腺癌和胰腺癌。公司于 2010 年8 月底正式获批，9 月份已经开始生产。今明两年将成为抗肿瘤产品线的一线品种，将迎来高速增长。预计，公司该品种将能达到4-6 亿元/年的销售规模。恒瑞医药是治癌药的标杆性企业，成长不封顶。<br><br>16.双鹭药业（002038）<br><br>公司主要产品贝科能即复合辅酶，主要含有辅酶A、辅酶I、三磷酸腺苷、还原型谷胱甘肽、核苷酸等生物活性物质，这些物质在人体代谢循环中起着重要的催化作用。很多疾病和治疗过程中的药品使用会导致人体代谢失衡，复合辅酶作为一种重要的辅助用药在各种疾病的治疗过程中起着重要的调节作用，目前在肝病，肿瘤，心血管领域应用广泛，参股南京卡文迪许公司也进一步的扩充了自己在肿瘤产品方面的实力。贝科能：新进医保将促进11 年产品销量大幅增长；北京地区四五年一度的药品招标于今年开始，产品有望进入部队医院以外的多家新医院，预计11 年北京市场增长也将超预期：今年新进河北、贵州、新疆、四川、河南几个人口大省医保，江苏医保处于公示阶段，北京医保进入可能性依旧很大，浙江医保可能半年后进入。我们认为进入医保尚未对产品今年的销售产生影响，预计明年新进医保几大省市该产品销量可增长1-3 倍。胸腺五肽产品可迎来新增长：胸腺五肽成为医院肿瘤临床常规用药，促进产品新增长；海南竞争者被吊销GMP 执照，提高公司市场份额。<br><br>17.海南海药（000566）<br><br>公司最早的紫杉醇是典型的抗肿瘤药，可用于治疗卵巢癌、乳腺癌、肺癌、鼻咽癌。<br><br>18.双鹤药业（002038）<br><br>公司主营业务为肿瘤、心脑血管疾病、肝炎、器官移植领域的基因工程药、化学、生化药的研发生产。<br><br>19.安科生物（300009）<br><br>公司与合肥医工医药就替吉奥片剂的生产技术及新药证书、生产批件转让进行合作。替吉奥片剂由合肥医工医药开发，于2007年获得临床批件，目前正在进行临床试验，预计2012年可以投产销售。替吉奥是一种复方抗肿瘤新药，主要用于治疗晚期或转移性胃癌，预计2012年投产，年生产能力为3000万片。资料显示，替吉奥片剂目标是适应症如肝癌、非小细胞肺癌，及其他消化系统肿瘤的临床研究正在进行中未来替吉奥片治疗适应症的增加必将令其医药临床应用范围更加广泛。<br><br>20.西南合成（000788）<br><br>公司与方正医药研究院合作的康普瑞丁磷酸二钠（CA4P）及注射剂是一种血管靶向药物或内皮破坏药物，其机理是引起肿瘤血流供应迅速中断导致肿瘤由于供氧不足和营养饥饿而死亡，该药生产批件需耗时5-6年左右。——“太极系”<br><br>21.太极集团（600129）<br><br>公司拥有具有自主知识产权的抗癌药物新制剂，并且力争于2010年底完成临床批文申报。——“太极系”<br><br>22.复星医药（600196）<br><br>公司持股74%的上海复宏汉霖生物技术致力于大分子单克隆抗体药物的研发和产业化工作；公司与国际医药企业Chemo集团在上海凯茂生物医药平台上建设的单克隆抗体药物项目将引进4个治疗肿瘤和类风关单克隆抗体药物。——“复兴系”<br><br>23.中新药业（600329）<br><br>公司持股40%的华立达生物工程率先通过基因工程制药技术致力于抗病毒、抗肿瘤药物的研究开发和产业化，拥有主导产品&#34;安福隆&#34;－第二代基因工程α-2b干扰素。<br><br>24.华润三九（000999）<br><br>公司持股83.68%的安徽金蟾生化主要生产抗癌用药华蟾素注射液，可用于中、晚期肿瘤，慢性乙型肝炎等症得治疗。——“华润系”<br><br>25.誉衡药业（002437）<br><br>公司生产有抗肿瘤药物盐酸吉西他滨主要用于治疗胰腺癌和非小细胞肺癌（目前我国仅有美国礼来、江苏豪森和誉衡药业三家药厂生产该药物）。<br><br>26.莱美药业（300006）<br><br>公司核心技术有淋巴靶向治疗的纳米药物技术、药物微纳米分散及混悬制备技术和无菌原料药制备技术，其中，淋巴靶向治疗的纳米药物技术处于国际领先水平；抗肿瘤药物主要为纳米炭混悬注射液，注射用磷酸氟达拉滨，肠外营养药主要为N（2）-L-丙氨酰-L-谷氨酰胺注射液。<br><br>27.人福医药（600079）<br><br>公司持有81.07%股权的湖北葛店人福药业是一家专业从事甾体激素类原料药、生育调节药物和抗肿瘤药物的研发生产企业；公司持有52%股权的深圳新鹏生物工程正在研发国际领先的抗癌基因药项目TR-1药品，有望在3-5年内取得一类新药证书。<br><br>28.吉林敖东（000623）<br><br>公司控股子公司延吉药业拥有的“注射用复方胰核糖核酸的制备方法”专利是以牛胰脏为原料，具有抗癌、抗衰老、增强免疫力功能，减轻放、化疗毒副反应，使癌细胞引起空泡样变性，癌细胞溶解。<br><br>29.中汇医药（000809）<br><br>公司拥有辅助治疗肿瘤化疗的川黄口服液和治疗妇女子宫肌瘤的宫瘤清胶囊。<br><br>30.独一味（002219）<br><br>公司拥有宫瘤宁胶囊产业化项目；独一味草除具有消肿、镇痛止血之主药效外，还具有调节免疫、抑菌消炎、抗肿瘤功效。<br><br>31.桂林三金（002275）<br><br>公司在研项目包括有癌症治疗领域。<br><br>32.天士力（600535）<br><br>公司与法国TRANSGENE组建的天士力创世杰(天津)生物制药将致力转基因技术用于癌症和传染性疾病基因免疫治疗。<br><br>33.益佰制药（600594）<br><br>公司拥有基因技术的抗肿瘤中药艾迪注射液产品，另外购买的可使用基因工程方法获取多肽链类产品的VEGI专有技术，可直接激活不同类型免疫细胞以抑制或消除癌细胞。<br><br>34.哈药股份(600664)<br><br>主要产品是化症回生口服液和转移停胶囊。化症回生口服液和转移停胶囊均为独家的中药三类新药。化症回生口服液是从传统中药中提取的纯天然抗癌药物；转移停胶囊的抗癌症转移效果非常显著。","source":"雪球"},{"id":22842917,"user_id":6785033954,"title":"纳入大病保障范畴的20种疾病","created_at":1358382012000,"retweet_count":1,"reply_count":0,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"据央视消息，记者今日从卫生部了解到，2013年，我国农村医疗保障重点将向大病转移。包括儿童白血病、先心病、末期肾病、乳腺癌、宫颈癌、重性精神疾病、耐药肺结核、艾滋病机会性感染、血友病、慢性粒细胞白血病、唇腭裂、肺癌、食道癌、胃癌、I型糖尿病、甲亢、急性心肌梗塞、脑梗死、结肠癌、直...","type":"1","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22842917","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":521,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-17 08:20","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"据央视消息，记者今日从卫生部了解到，2013年，我国农村医疗保障重点将向大病转移。包括儿童白血病、先心病、末期肾病、乳腺癌、宫颈癌、重性精神疾病、耐药肺结核、艾滋病机会性感染、血友病、慢性粒细胞白血病、唇腭裂、肺癌、食道癌、胃癌、I型糖尿病、甲亢、急性心肌梗塞、脑梗死、结肠癌、直肠癌等20种疾病全部纳入大病保障范畴，报销比例不低于90％。","source":"雪球"},{"id":22842877,"user_id":6785033954,"title":"1949点反弹以来滞涨股：13股不涨反跌","created_at":1358380947000,"retweet_count":6,"reply_count":4,"fav_count":10,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"1949点反弹以来滞涨股：13股不涨反跌 自1949点反弹以来，大盘反弹幅已经超过300点，如今已经成功站上2300点。在这段上涨区间内，两市有6只个股涨幅翻倍，133只个股涨幅超过50%，但是依然有不少个股跑在了后面，甚至有不少个股甚至是&#34;零涨幅&#34;。(证券时报网) 今日从中选出区间涨跌较小者乃至...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22842877","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":820,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-17 08:02","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"1949点反弹以来滞涨股：13股不涨反跌<br>　　自1949点反弹以来，大盘反弹幅已经超过300点，如今已经成功站上2300点。在这段上涨区间内，两市有6只个股涨幅翻倍，133只个股涨幅超过50%，但是依然有不少个股跑在了后面，甚至有不少个股甚至是&#34;零涨幅&#34;。(证券时报网)<br>　　今日从中选出区间涨跌较小者乃至负者50股，供投资者参考。<br>代码简称1949点以来振幅（%）区间最高价（元）区间最低价（元）区间换手率（%）最新价（元）区间涨跌幅（%）市盈率TTM（倍）<br>002317众生药业29.9139.0027.71111.9634.48-8.6636.94<br>000815*ST美利22.055.944.6348.275.56-6.40-10.21<br>601137博威合金15.3617.3014.8073.1015.63-3.9929.36<br>000509SST华塑15.5911.119.5148.759.86-3.90-58.17<br>600306商业城22.5711.759.40116.4110.06-3.36473.00<br>600381贤成矿业24.055.234.09304.964.61-2.74-140.73<br>600053中江地产20.398.006.5262.267.08-2.482301.45<br>600771ST东盛19.559.307.6539.868.31-1.54-31.16<br>600011华能国际14.657.406.428.096.62-1.0522.96<br>000766通化金马14.905.464.6641.455.34-0.56-492.14<br>002555顺荣股份11.3811.4610.20178.4911.03-0.36102.44<br>600483福建南纺13.905.975.1596.385.88-0.3448.57<br>600617ST联华13.429.508.3113.698.84-0.341049.27<br>600190锦州港6.323.723.497.853.650.2743.01<br>002051中工国际17.8130.6825.6621.6328.280.3226.77<br>600518康美药业24.1215.5312.0570.6914.480.3523.23<br>600149廊坊发展19.049.628.00161.778.560.5958.42<br>000638万方地产19.258.106.76117.477.091.87-143.47<br>601880大连港6.122.902.7348.212.842.1622.15<br>600074中达股份29.084.793.6592.414.012.30-24.14<br>600087*ST长油18.601.481.2426.621.333.10-3.90<br>600728佳都新太8.298.778.081.678.623.6159.25<br>000712锦龙股份6.1811.2310.573.0111.103.93315.52<br>600253天方药业16.726.805.7441.076.604.10111.94<br>000607华智控股13.214.664.0831.874.604.7858.65<br>600777新潮实业11.955.254.6831.055.004.82-103.31<br>600667太极实业25.144.273.39201.073.674.8694.30<br>000030*ST盛润A19.259.627.88102.569.484.87-741.18<br>000633ST合金14.176.495.657.246.224.89-132.04<br>601018宁波港6.942.602.4326.432.574.9011.67<br>002153石基信息14.7322.0019.0118.7821.304.9324.26<br>600519贵州茅台18.48221.00184.0016.48210.855.3217.35<br>000511银基发展8.824.003.6760.163.945.35192.24<br>601005重庆钢铁26.353.953.0777.253.525.39-2.29<br>601919中国远洋10.854.664.2011.034.475.42-3.78<br>600155*ST宝硕14.673.402.9615.963.175.670.63<br>600448华纺股份14.174.293.7590.944.035.7781.25<br>600547山东黄金11.4838.2634.1832.3137.665.9426.19<br>601766中国南车8.885.204.7714.185.135.9918.16<br>600961株冶集团12.7310.749.5146.6310.246.00-7.13<br>601857中国石油8.039.148.460.399.036.6114.19<br>600462*ST石岘16.714.623.9317.234.416.78-3.29<br>600693东百集团17.147.476.3336.007.116.9228.68<br>600870ST厦华12.674.063.5918.313.977.01-2728.76<br>600798宁波海运15.903.733.2115.513.507.03-27.51<br>000760博盈投资20.498.747.1480.458.387.30-233.83<br>600880博瑞传播25.3211.138.52172.8311.077.3719.44<br>600017日照港9.592.932.677.742.917.3813.50<br>600575芜湖港17.467.706.5213.407.267.4023.03<br>600744华银电力16.574.153.56194.833.837.58-28.36","source":"雪球"},{"id":22841404,"user_id":6785033954,"title":"生产抗癌药物的上市公司资料","created_at":1358349023000,"retweet_count":24,"reply_count":20,"fav_count":62,"truncated":false,"commentId":0,"retweet_status_id":0,"symbol_id":null,"description":"今天傍晚看到新闻：农村大病医保扩容 肺癌胃癌等纳入，【大病保障扩容20种大病报销超九成】2013年，我国农村医疗保障重点将向大病转移。肺癌、胃癌等20种疾病全部纳入大病保障范畴，报销比例不低于90%。 好消息啊好消息，为农村老百姓高兴。紧急找到以下资料和各位朋友分享，本人明天也找机会参与...","type":"3","source_link":null,"edited_at":null,"pic":"","user":{"subscribeable":false,"status":1,"common_count":0,"remark":null,"name":null,"location":null,"id":6785033954,"type":"1","url":null,"description":"如果不上雪球，你就输在了投资的起跑线上。","domain":null,"stats":null,"blocking":false,"screen_name":"zangyn","verified":false,"verified_type":0,"st_color":"1","allow_all_stock":false,"following":false,"donate_count":47,"verified_description":null,"profile":"/6785033954","status_count":7506,"last_status_id":39401690,"follow_me":false,"friends_count":647,"city":"澳大利亚","gender":"m","followers_count":200896,"province":"海外","recommend":null,"blog_description":null,"step":"three","intro":null,"stock_status_count":null,"stocks_count":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/201210/1352439404964-20121221.png,community/201210/1352439404964-20121221.png!180x180.png,community/201210/1352439404964-20121221.png!50x50.png,community/201210/1352439404964-20121221.png!30x30.png"},"retweeted_status":null,"target":"/6785033954/22841404","fragment":null,"blocked":false,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":1029,"mark":0,"favorited":false,"favorited_created_at":null,"timeBefore":"2013-01-16 23:10","expend":true,"canEdit":true,"firstImg":null,"topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"今天傍晚看到新闻：农村大病医保扩容 肺癌胃癌等纳入，【大病保障扩容20种大病报销超九成】2013年，我国农村医疗保障重点将向大病转移。肺癌、胃癌等20种疾病全部纳入大病保障范畴，报销比例不低于90%。<br>好消息啊好消息，为农村老百姓高兴。紧急找到以下资料和各位朋友分享，本人明天也找机会参与一把。<br>　　&nbsp; &nbsp;目前全球各国已批准上市的抗癌药物大约有130 ～150种。各种抗癌药物制剂大约有1300～1500种。目前在抗癌药物分为西药和中药两大类。西药中包括化疗和生物靶向治疗药物等，中药包括临床上常用的方剂药物和中成药。我国恶性肿瘤的发病率不断上升，成为第一位致死疾病。在众多抗肿瘤药中，天然植物类抗肿瘤药所占的比重最大，占据了27.0%的份额，其次为抗代谢类肿瘤药，占26.1%。在单品排名前10位的抗肿瘤药中，植物类抗肿瘤药占据了前两个席位，为紫杉醇和多西他赛。预计今后5～10年内，以单克隆抗体、生物工程疫苗和反义寡核苷这3类生物工程抗癌药将居世界抗癌药物市场的统治地位。<br><br> &nbsp;《生物产业发展“十二五”规划》确定了我国生物科技与产业发展的八个重点包括：⑴加强生命科学前沿技术研究；⑵加速推进农业生物技术，培育转基因动植物新品种，特别是培育抗旱抗盐碱的植物新品种，大幅度提高农作物的材质、质量品质，开发生物肥料、生物农药、可降解地膜、新型食品与饲料添加剂等新产品。⑶大力发展生物医药技术，重点支持疾病预防、疾病诊断、新药研制、基因治疗、试管移植等技术，为全面提高人民健康水平提供有力支撑。⑷大力发展工业生物技术，发展现代发酵、生物催化等新技术，促进传统产业的升级改造，推进绿色制造业发展。⑸加速发展生物质能，缓解能源短缺的压力。⑹加速环境生物技术研究与应用，不断改善生态环境。⑺加强生物资源深度开发，培育一批新的生物产业。⑻加强生物安全研究，确保国家生物安全。<br><br> &nbsp;&nbsp;生物医药“十二五规划”确定了生物医药发展的重点，包括基因药物、蛋白药物、单克隆抗体药物、治疗性疫苗、小分子化学药物等，同时国家将拿出100多亿元来支持重大新药创制。国家将从100多个新药中遴选出10多个，作为重大新药创制重点支持对象，这些原创新药可能成为打入欧美市场的先锋。在这些品种中，生物药和化学药居多，其中疫苗、单克隆抗体、蛋白质药物、抗癌药物等均有。<br>A股生产抗癌药物概念股：<br> &nbsp;&nbsp;&nbsp;1、华神集团(000790)：公司拥有的原发性肝癌药碘[131I]美妥昔单抗注射液(利卡汀)是国家一类创新药，是全球第一个运用单克隆抗体靶向治疗肝癌的基因药品，公司具有自主知识产权用于中晚期肝癌治疗。<br> &nbsp;&nbsp;2、益佰制药(600594)：公司拥有基因技术的抗肿瘤中药艾迪注射液产品，另外购买的可使用基因工程方法获取多肽链类产品的VEGI专有技术，可直接激活不同类型免疫细胞以抑制或消除癌细胞。<br> &nbsp;&nbsp;3、恒瑞医药(600276)：公司单一对映体的手性药物—左亚叶酸钙可用于增强5-氟尿嘧啶的抗肿瘤活性，主要治疗骨肉瘤经大剂量甲氨蝶呤治疗后与叶酸拮抗相关的症状和结肠癌、肾癌；公司多种抗肿瘤药品在国内排名第一，其中3个产品为国内独家生产，现有仿制药奥沙利柏、多西他赛处于成长期，伊利替康也正在进入快速成长期；公司要拥有分子靶向抗肿瘤药物甲磺酸阿帕替尼。<br> &nbsp;&nbsp;4、誉衡药业(002437)：盐酸吉西他滨--抗肿瘤用药：注射用盐酸吉西他滨属于抗代谢肿瘤药，被广泛应用于治疗胰腺癌和非小细胞肺癌，我国仅有美国礼来、江苏豪森和誉衡药业三家药厂生产。<br> &nbsp;&nbsp;5、莱美药业(300006)：公司核心技术有淋巴靶向治疗的纳米药物技术、药物微纳米分散及混悬制备技术和无菌原料药制备技术，其中，淋巴靶向治疗的纳米药物技术处于国际领先水平；抗肿瘤药物主要为纳米炭混悬注射液，注射用磷酸氟达拉滨，肠外营养药主要为N(2)-L-丙氨酰-L-谷氨酰胺注射液，填补了国内空白，临床应用价值巨大。<br> &nbsp;&nbsp;&nbsp;6、四环生物(000518)：公司主要产品包括一类抗癌新药注射用重组人白介素-2(用于肾癌、恶性黑色素瘤以及其他恶性肿瘤综合治疗)、重组人白介素-2注射液、重组人粒细胞刺激因子注射液、重组人促红素注射液，其中注射用重组人白介素-2是国家项目“基因工程人白细胞介素-2的研制、中试生产及临床应用”产业化基因工程产品；目前仍持有55%股权的北京四环生物制药是我国最早从事基因工程药品和诊断试剂研究生产的企业，其专有技术包括白介素2(用于肝癌治疗)、干扰素、EPO、G-CSF等舌下含片。<br> &nbsp;&nbsp;7、安科生物(300009)：公司拟引进抗肿瘤药物替吉奥片剂项目，替吉奥是一种复方抗肿瘤新药，主要用于治疗晚期或转移性胃癌，预计2012年投产，年生产能力为3000万片。<br> &nbsp;&nbsp;8、丰原药业(000153)：公司与中人科技合资的丰原中人药业(公司占60%股权)保证顺铂植入剂抗癌新药在2012年9月底前上市；公司大力投入癌症辅助治疗新药研发工作。<br> &nbsp;&nbsp;9、普洛股份(000739)：公司持有98.07%的浙江普洛康裕制药生产的百士欣是国家二类抗肿瘤新药；公司2010年上半年申报的“基因工程酶法合成D-对羟基苯甘氨酸邓钾盐高技术产业化示范工程”被列入国家高技术产业化示范项目。<br> &nbsp;&nbsp;10、西南合成(000788)：公司与方正医药研究院合作的康普瑞丁磷酸二钠(CA4P)及注射剂是一种血管靶向药物或内皮破坏药物，其机理是引起肿瘤血流供应迅速中断导致肿瘤由于供氧不足和营养饥饿而死亡，该药生产批件需耗时5-6年左右。<br> &nbsp;11、海正药业(600267)：公司是中国领先的原料药生产企业，是中国最大的抗生素、抗肿瘤药物生产基地之一；公司在建制剂出口基地项目年产细胞毒抗肿瘤药水针剂2500万瓶、冻干粉针2500万瓶、固体制剂1.6亿片粒；公司基因药物肿瘤坏死因子受体抗体融合蛋白目前已进入II期临床试验阶段。<br> &nbsp;12、海南海药(000566)：公司主要产品包括抗肿瘤药紫杉醇注射液，可用于治疗卵巢癌、乳腺癌、肺癌、鼻咽癌。<br> &nbsp;&nbsp;13、华润三九(000999)：公司持股83.68%的安徽金蟾生化主要生产抗癌用药华蟾素注射液，可用于中、晚期肿瘤，慢性乙型肝炎等症得治疗。<br> &nbsp;&nbsp;14、人福医药(600079)：公司持有81.07%股权的湖北葛店人福药业是一家专业从事甾体激素类原料药、生育调节药物和抗肿瘤药物的研发生产企业；公司持有52%股权的深圳新鹏生物工程正在研发国际领先的抗癌基因药项目TR-1药品，有望在3-5年内取得一类新药证书。<br> &nbsp;&nbsp;15、江苏吴中(600200)：控股子公司吴中医药目前在研“国家一类生物抗癌新药重组人血管内皮抑素注射液获得的研发与产业化”项目处于申请三期临床研究阶段，具有自主知识产权，2006年曾获国家“863”项目支持，用于非小细胞肺癌。2010年11月，获得江苏省科技成果转化专项资金扶持(共计1000万元及配套项目经费200万元)，将为该项目的三期临床研究工作和今后的产业化提供重要的资金保证。<br> &nbsp;&nbsp;&nbsp;16、海欣股份(600851)：自主研发国家一类新药，该药品叫“抗原致敏的人树突状细胞(APDC)”，可用于治疗直肠癌，由海欣生物技术公司(公司持股51%)与上海第二军医大学合作研发，国家一类新药，是我国首个自主研发获得国家食品药品监督管理局(SFDA)正式批准，针对晚期大肠癌APDC治疗性疫苗，09年年报披露，三期临床已通过国家药监局组织专家论证，批文正在审批之中，该企业经过努力，获得国家“重大新药创制”基金近500万元。<br> &nbsp;&nbsp;17、亚泰集团(600881)：投资医药行业——公司以生物疫苗和抗肿瘤系列药为新品开发方向，已形成以“参一胶囊”，抗癌生物导弹为主导抗癌系列产品，同时还储备白介素－11，人参皂甙Rg3注射剂等在研抗癌新药。主导产品人参皂苷Rg3及其制剂参一胶囊，是我国第一个被批准生产国家一类中药单体抗癌新药。参与研发新型系列抗癌生物导弹药物比欧米赛Ⅰ期临床试验于2005年6月开始，至2007年2月结束，开始进入II期临床试验研究阶段，该药物作为国家治疗用生特制品一类新药。<br> &nbsp;&nbsp;18、双鹭药业(002038)：公司入选“北京生物医药产业跨越发展工程”和中关村国家自主创新示范区首批“十百千工程”重点培育企业。公司在肿瘤治疗，抗炎镇痛，心脑血管和肝病等领域已储备多个具有国内外市场潜力的优势大品种，力争推出3个以上的抗体和疫苗药物。在肝病治疗领域不断培育重磅品种，力争成为国内肝病治疗领域的重要企业。公司主打品种重组人粒细胞集落刺激因子，白介素－11，门冬酰胺酶，抗肿瘤产品等10余个品种正陆续进入东欧，亚洲，南美市场。<br> &nbsp;&nbsp;19、兰生股份(600826)：公司参股34.65%兰生国健药业与中信泰富共同投资成立“上海中信国健药业有限公司”，兰生国健占41.69%，公司占0.73%。08年中信国健研制的生物新药“益赛普”(注射用重组人11型肿瘤坏死因子受体-抗体融合蛋白)荣获国家科学技术发明奖二等奖，是我国第一个真正实现产业化并上市销售的人源化单克隆抗体类药物。已完成4条750升细胞培养生产线建设并顺利投产，年生产能力达到毫克级装药量400万支。兰生股份(600826)：公司参股34.65%兰生国健药业与中信泰富共同投资成立“上海中信国健药业有限公司”，兰生国健占41.69%，公司占0.73%。08年中信国健研制的生物新药“益赛普”(注射用重组人11型肿瘤坏死因子受体-抗体融合蛋白)荣获国家科学技术发明奖二等奖，是我国第一个真正实现产业化并上市销售的人源化单克隆抗体类药物。已完成4条750升细胞培养生产线建设并顺利投产，年生产能力达到毫克级装药量400万支。<br><br> &nbsp;&nbsp;20、太极集团(600129)：与科研院所联合开发4个具有自主知识产权的新药：抗癌药物新制剂、糖尿病（并发症）新药及 2 个心血管新药，其中2个已获临床批件，1个正在申报生产批件，自主筛选了 901、902、903、904、905新产品项目。2009 年科技创新工作为打造创新型企业奠定了坚实的基础。<br><br> &nbsp;&nbsp;&nbsp;以上20个上市公司紧急加入自选股池，明天备用！","source":"雪球"}],"page":367};
  SNB.data.statusType = "";
  SNB.data.isSelf = false;
  SNB.data.who = '他';
  SNB.data.route = '';
  seajs.use(['SNB.status.js', 'SNB.newProfile.js']);
})($);</script></div><script>seajs.use(['widget/donate_tooltip'], function () {
  $('body')
    .on('click', function (e) {
      var $this =  $(e.target);
      
      if (!$this.parents('.set-sub-menu').length) {
        $('.set-sub-menu').hide();
      }
    })
    .on('mouseenter', '.status-list li', function () {
      var $this = $(this);
      
      if ($this.find('.btn-sub-menu').length) {
        $this.find('.btn-sub-menu').addClass('hover');
      }
    })
    .on('mouseleave', '.status-list li', function () {
      var $this = $(this);
      
      if ($this.find('.btn-sub-menu').length) {
        $this.find('.btn-sub-menu').removeClass('hover');
      }
    });
});

</script></div></div></div><div id="footer"><div class="risk">提示：雪球里任何用户或者嘉宾的发言，都有其特定立场，投资决策需要建立在独立思考之上。</div><div class="copyright"><a href="/about/faq" target="_blank">常见问题</a><a href="/about/contact-us" target="_blank">联系方式</a><a href="/about/jobs" target="_blank">加入我们</a><a href="/about/company" target="_blank">关于雪球</a><a>© 2015 XUEQIU.COM</a><a href="http://www.miibeian.gov.cn/" target="_blank">京ICP证100666号</a><span>京公网安备 11010502026957</span></div></div><script>var _hmt = _hmt || [];
(function () {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?1db88642e346389874251b5a1eded6e3";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();</script><script>var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-16079156-4']);
_gaq.push(['_setDomainName', 'none']);
_gaq.push(['_trackPageview']);

(function () {
  var ga = document.createElement('script');
  ga.type = 'text/javascript';
  ga.async = true;
  ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
  var s = document.getElementsByTagName('script')[0];
  s.parentNode.insertBefore(ga, s);
})();

window.onerror = function (message, file, line) {
  var sFormattedMessage = '[' + file + ' (' + line + ')]' + message;
  _gaq.push(['_trackEvent', 'Exceptions', 'Application', sFormattedMessage, null, true]);
}</script><script>jQuery(function ($) {
  $('.cube-invite').on('click', function () {
    var href = $.trim($(this).attr('href'));
    if (window._hmt) {
      _hmt.push(['_trackEvent', 'cube-invite', 'click', href]);
    }
  });
});</script></body></html>